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Abstract
Natural products remain the most common source for drug leads, although
diversity-oriented synthesis of unnatural complex molecules is gaining momentum. Our
lab has been developing experimentally simple and straightforward approaches to complex
molecular architectures via photochemical reactions involving a minimal number of
experimental steps. In order to achieve this, photoprecursors were assembled via high
yielding reactions. Next, we deployed photoinduced cycloadditions to create complex 3dimentional structures. Lastly, with this obtained primary photoproduct, postphotochemical transformations were used to further grow its scaffold complexity.
One method to increase scaffold complexity is the [4+2] intramolecular
cycloadditions of azaxylylenes, which are developed through standard amide bondforming reactions. The intermediates are produced by the excited state intramolecular
proton transfer (ESIPT) from photoprecursors that could be trapped intramolecularly by
tethered

unsaturated

pendants.

Understanding

intramolecular

cycloaddition

of

azaxylylenes allows for the access to other derivatives of these complex molecules, with a
particular focus on heterocycles. Also, the awareness of photoassisted intermediates via
excited state intramolecular proton transfer helped us implement [4+2] cycloadditions,
which gave us rapid access to complex nitrogen heterocycles possessing natural productlike privileged substructures. The primary photoproducts were introduced to postphotochemical transformations, including classical elimination of the scaffold and
ii

decarboxylative elimination. Through this base-catalyzed modification, we were able to
access flat, aromatic, and complex heterocycles.
With underutilization of photochemistry and the need of aromatic polyheterocycles,
we tailored photoprecursors to target specific compounds that have never been synthesized
before but are targeted for biological testing. In addition to unnatural polyheterocycles, we
targeted natural products that are biologically active. We continued our studies to modulate
the biological activity of final compounds through methylation of the pyridine; all these
products were submitted to National Cancer Institute for NCI-60 testing against 60 most
common human cancer cell lines. During our studies, we derived an unusual rearrangement
that undergoes a retro-Claisen condensation producing pyridopyrimidine.
Our focus in the synthesis of photoassisted intramolecular cycloadditions will help
develop complex compounds in drug discovery. Method development for synthesis of
these highly sought-after sp3 carbon rich photoprecursors has the potential to lead to the
discovery of new materials. Photochemistry is slowly earning its deserved place in the
arsenal of synthetic methods, and our successful synthetic photochemistry research
program will further encourage the utilization of these methods in medicinal chemistry and
make a greater impact in the academic and industrial community.
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Chapter One
Photochemical and post-photochemical synthetic sequence to access complex
aromatic polyheterocycles
Quinolines have been studied extensively for their documented biological activity;
therefore, molecular modifications of these privileged substructures are desirable. Due to
the pharmacological properties of quinolines and its derivatives, many have reported
synthetic routes to obtain these desired products.
These polyheterocyclic compounds have been produced in a multi-step synthesis
or with costly/exotic starting materials.5 With our click-like photochemical approaches, we
are able to access advanced heterocyclic molecules in minimal costs and time (2-3 steps).
Additionally, we have proficiently directed a large variety of undescribed analogs through
target design. This will enable exploration of a variety of complex heterocyclic compounds
that have not been previously accessed since the current synthetic routes are difficult to
achieve.
1.1. Synthesis of Quinolines
1.1.1 Synthetic Routes to Quinoline Derivatives
Quinolines have been studied extensively and originally synthesized through the
Friedlӓender reaction. The starting materials for this reaction are o-aminoaryl aldehydes or
ketones and a ketone with an active methylene group.
1

The Friedlӓender synthesis is the first synthetic pathway to quinolines.

As the

increasing number of studies show useful antimalarial, antimicrobial, and fungicidal
properties of these N-heterocycles and new structural analogues, there is an incentive for
continued developments of new practical methods of quinoline synthesis. It is important
for the pharmaceutical industry.
Another chemical reaction used to synthesize quinolines is the Skraup reaction.
This reaction heats an aniline with sulfuric acid, glycerol, and an oxidizing agent, which
has a reputation for being very violent and dangerous.

Skraup was able to develop another reaction that was less violent, the SkraupDoebner-Von Miller synthesis.31 This reaction uses anilines and α,β – unsaturated carbonyl
compounds which is catalyzed by Lewis acids and Brᴓnsted acids to form quinolines. The
mechanism is still a matter of debate.

2

In 1888, the Combes quinoline synthesis was first reported which involved the
condensation of unsubstituted anilines with β – ketones to form quinolines.32 The imine
intermediate in the reaction would undergo an acid-catalyzed ring closure.

Figure 1.1: Mechanism of Combes quinoline synthesis

Figure 1.1 shows the reaction mechanism of Combes quinoline synthesis.33 The
first step is the protonation of the oxygen on the β – diketone which reacts with the aniline
under a nucleophilic addition. Next, is the proton transfer and an E2 mechanism which
allows a water molecule to leave. A Schiff base is generated with deprotonation of the
nitrogen atom, which tautomerizes to form an enamine. Next, is the annulation of the
molecule, followed by a proton transfer. The alcohol is protonated allowing for a
dehydration of the molecule, resulting in a quinoline product. Though, there are simple
3

methods on synthesizing quinolines, labs continue to expand the studying of quinoline
synthesis, especially quinolines with a variety of substituents for late stage
functionalization.

Figure 1.2: Aerobic oxidative aromatization to form quinolines

Jixing La et al. assembled substituted quinolines by aerobic oxidative aromatization
from easily accessible alcohols and anilines. Their intended assembly was to achieve a
protocol that can be easily scaled up to a multigram-scale and can be utilized in a formal
synthesis in pharmaceuticals.28 In Figure 1.2, they were able to synthesize versatile
quinolines in high yields by an aerobic oxidative aromatization of aliphatic alcohols and
anilines permitted by Pd(OAc)2/Brønsted acid catalysis. This method has many
advantages: cheap starting materials, variety of functional groups, and O2 as the oxidant;
however, there were many challenges. The challenges were chemoselectivity vs Nalkylation, side-oxidation of starting materials, and coordination effects of quinoline
products.
Quinolines that contain thiophene and furan have been studied extensively for its
biological activity. The most current article published by Chen et al., showed interest in
design, synthesis and antifungal evaluation of fully aromatized heterocycles containing
quinoline cores. They were limited on their scope of substrates; moreover, their synthetic
4

route is roughly 5-6 steps (Figure 1.3).6 Chen et al. did not have one general procedure to
target a variety of compounds; each quinoline had a different synthetic route. Because there
were multiple procedures to synthesize quinolines, it was difficult for them to isolate and
test these derivatives. Because there were issues with their synthesis, they mentioned that
they purchased quinolinone 1.4 to react with phosphorus oxychloride, then compound 1.5
was reduced to give product 1.6.

Figure 1.3: Chen et al. proposed synthesis of quinoline derivatives

Looking over recent literature, it is evident that labs are only changing the synthetic
routes to quinolinone 1.4 and keeping the synthetic route from 1.4 to 1.6 the same.
Unfortunately, there are not many general procedures to target these quinoline derivatives
with simple, high yielding steps. These quinoline derivatives are desired for their biological
activity, which continue to be studied. Figure 1.4 shows that the salicylonitrile or
thiosalicylnitrile 1.7 reacted with phenylacylbromide 1.8 in DMF under basic conditions.
Next, nucleophilic cyclization of the fluoro-derivative with sodium hydride in DMF
produced quinolinone 1.4 in moderate yields.7 Benzothieno [3,2-b]quinoline and
benzofuro[3,2-b]quinoline 1.6 were synthesized from quinolinone 1.4 via reductive
dechlorination; however this was described before.
5

Figure 1.4: Synthesis of benzothieno [3,2-b]quinoline and benzofuro[3,2-b]quinoline

Continuing to look at previous literature, we noticed there were no developing
synthetic routes to these valuable quinoline derivatives, which gives limitations to the
scope and diversity of quinoline mini libraries. Most published research had the same route
from the quinolinone 1.4 to the quinoline 1.5 shown in Figure 1.3 and 1.4. However, Bein
and Knochel studied cobalt-catalyzed electrophilic aminations with anthranils to achieve
access to condensed quinolines.8

Figure 1.5: Cobalt-catalyzed amination of (hetero)arylzinc pivalates with anthranils

Bein and Knochel used alkenylzinc pivalates, electron-rich arylzinc pivalates, or
heterocycliczinc pivalates to directly achieve quinolines. Anthranil 1.14 reacted with zinc
6

pivalate 1.16 to provide product 1.17 via a Friedel – Crafts reaction. The optimized
conditions show that PhZnOPiv reacts best with anthranil in the presenece of 10 mol % of
CoCl2 at 23 oC for 16 hours to provide the aldehyde in Figure 1.5.

Figure 1.6: Synthesis of quinoline derivatives

Bein and Knochel were able to extend the preparation of quinoline derivatives with
the treatment of various anthranils with alkenyl pivalates. Under standard conditions, they
observed electrophilic animation followed by cycloisomerization, which provided
quinolines 1.23-1.25 (Figure 1.6).

7

1.2 Reactivity of Aza-o-xylylenes
1.2.1 Photoassisted Transformation
The novelty in this research is to access complex, conjugated poly-heterocyclic
systems, which are achieved through versatile precursor design. Photochemistry has
allowed for the access to complex architectures that are challenging, if not impossible to
achieve in the ground state. The photoassisted intramolecular transformation offers fast
access to novel poly-heterocyclic molecular architectures. Cycloadditions of aminosubstituted azaxylylenes, specifically [4+2] Diels – Alder, allows for complexity of such
poly-heterocyclic scaffolds. Earlier, our lab developed a synthetic route to achieve diverse
poly-heterocycles with a minimal and strategic synthetic sequence.2
Tethering a photoactive core to an unsaturated pendant using a scaffold/linker,
followed by an elimination of the scaffold, allows us to retrieve the complex heterocyclic
system. The scope of this reaction is amplified with the variety of unsaturated pendants,
from simple alkenes to dienic heterocycles such as: thiophenes, furans, or pyrroles. These
photoproducts are amenable to post-photochemical transformations to further grow its
complexity.
Our lab has demonstrated that this photoactive core is utilized through the benefit
of an excited state intramolecular transfer (ESIPT) in aromatic aldehydes via the
intermediacy of aza-o-xylylenes. ESIPT is known to occur in several hydrogen-bond
donor-acceptor pairs, especially in ortho-substituted aromatic compounds (Figure 1.7). We
have previously rationalized that the proton transfer must happen faster than the rotational
dissipation of excitation, with the attempt to intramolecular trap the excited state
8

azaxylylene.1 The photoassisted intramolecular transformation offers rapid access to
complex polyheterocycles.

Figure 1.7: ESIPT in aromatic aldehydes

1.2.2 Photophysical Properties
The photophysics of these processes were studied immensely using derivatives of
aminoanthraquinone because it contains a separate emission for each of the two tautomers
(Figure 1.8).5

Figure 1.8: Keto-Enol Tautomers of ESIPT producing

Smith and Barbara studied the excited-state properties of 1-(acylamino)
anthraquinones using a variety of physical techniques including: statistic fluorescence
spectroscopy, picosecond and subpicosecond time-resolved fluorescence techniques, and
picosecond transient absorption spectroscopy. Statistic fluorescence spectroscopy is a
powerful technique used to measure diffusion coefficients and chemical reaction rates with
9

high accuracy due to its ability to measure the relaxation of fluctuations of fluorescence
from a defined volume of the sample. With this, they found that the ESIPT emission was
100-300 fs, showing a very rapid ESIPT. Although the ESIPT is very rapid, it is not the
dominant process because the intersystem crossing from the S1 (N) to the S1 (T) is very
important in the formation of the intermediate (Figure 1.9). After intersystem crossing from
the S1(T) to the T1(T), the [4+2] cycloaddition occurs to yield the photoproduct. However,
if the S1(T) emits to the S(T), a back-proton transfer can occur to the normal structure.

Figure 1.9: Energy diagram of ESIPT

With the photophysics of ESIPT previously studied, Mukhina et al. wanted to study
the photogeneration of azaxylylenes via ESIPT in cycloaddition reactions. She was able to
form [4+4] and [4+2] photocyclization products through minimal synthetic steps (Figure
1.10).4
10

Figure 1.10: Photoinduced cyclization of amino benzaldehyde

After mechanistic studies, it was concluded that the amides of aromatic o-ketones
and aldehydes undergo fast and efficient ESIPT into their tautomeric form, azaxylylene.
Next, it was followed by intersystem crossing into the triplet state. The triplet azaxylylene
has a lifetime of up to 5 ns as it is quenched by an intramolecular reaction with the
unsaturated furyl pendant resulting in a [4+4] and [4+2] cycloaddition. There was no sign
that the cycloaddition reaction occurs in the singlet excited state.
The ESIPT is known to occur with hydrogen-bond donor-acceptor pairs, including
imines; therefore, Mukhina et al. wanted to study this through the photogenerated
azaxylylene intermediates. Due to the proton transfer happening on the same scale as the
rotational dissipation of excitation, photoassisted intramolecular transformations do occur
for imines.1 Mukhina et al. continued their studies in accessing novel poly-heterocyclic
molecular architectures by performing relative quantum yield experiments on the NMR
scale and demonstrating that several acyclic imine photoprecursors can yield [4+2] and
[4+4] photoproducts (Figure 1.11). Mukhina et al. monitored the reactions and recorded
the conversion of photoprecursor to photoproduct. With this data, Stern-Volmer
relationships allowed them to determine the relative quantum yields.

11

Figure 1.11: Photogeneration of azaxylylenes
(adopted from Angew. Chem. Int. Ed. 2015, 54,11516 –11520)

1.2.3 Diversifying the Scope to Aza-o-xylylene Intermediates
The complexity of these poly-heterocyclic molecules can be amplified through
post-photochemical transformations; furthermore, complexity can intensify by diversifying
the scope of the saturated and unsaturated pendants. Figure 1.12 demonstrates the heating
of the bicyclo[4.2.1]core 1.38, which formed the bicyclo[3.31]core product 1.40 thru a
rearrangement, allowing for diversification of the core by an effective method.

Figure 1.12: The [4.2.1] - [3.3.1] rearrangement
(adopted from Angew. Chem. Int. Ed. 2015, 54,11516 –11520)

12

Cyclic imine photoprecursors were used as the photoactive core to increase
complexity, which were expected to yield spiro-connected nitrogen heterocycles. The
photoprecursor 1.41 was designed to contain a pyrroline ring ortho to the amido moiety
and was irradiated to yield products [4+2] and [4+4] cycloaddition adducts, Figure 1.13.

Figure 1.13: Photocyclization of the pyrroline photoprecursor
(adopted from Angew. Chem. Int. Ed. 2015, 54,11516 –11520)

Now that the proof of concept worked efficiently with changing the unsaturated
pendant and modifying photoproducts through simple transformations, we could
strategically increase complexity and/or target complex cores. Next, our lab photoinduced
cyclizations with an easily accessible photoactive core of quinoxalinones and pyrrole
containing amino acid-based pendants, which yielded complex enantiopure heterocycles
(Figure 1.14). In this case, and confirmed with X-ray analysis, the major products were the
syn-[4+4] and anti-[4+2] adducts. In the optimization of irradiation conditions, Lewis acids
accelerated the reaction, with Ti(OiPr)4 being the best choice for its solubility in
dichloromethane.
13

Figure 1.14: Pyrrole-containing amino acid-based pendants yielding
complex enantiopure nitrogen heterocycles via photoinduced cycloadditions.
(adopted from Angew. Chem. Int. Ed. 2015, 54,11516 –11520)

The [4+2] cycloaddition products were modified by post-photochemical
transformations into sulfonylamidines 1.46 or diazacanes 1.47. These compounds contain
a spiroquinoxalinone moiety and five stereogenic centers.
1.2.4 Step-economical Assembly of Photoprecursors
With the success of Mukhina and lab members ability to successfully diversify
[4+2] and [4+4] cycloadditions with photophysical studies, Kuznetsov was able to take it
a step further by contributing step-economical synthesis of the precursors and sustaining
cascade photoreactions, which relentlessly increases the molecular complexity indices.
Kuznetsov rethought the role of the tether to assemble the photoprecursors to achieve
multifunctionality, which allowed for an efficient “assembly” of linear photoprecursors
14

with cost affective chemical feedstock. Kuznetsov reported that an oxalyl amide tether,
which is the linking of two aniline moieties with oxalyl chloride, can be carried out in a
one pot manner. As seen in Figure 1.15, the modular assembly of the photoprecursors offers
a straightforward access to cascade photochemical reactions.

Figure 1.15: Assembly of nonsymmetric oxalyl anilides photoprecursors

The irradiation of photoprecursor 1.52 generates a triplet aza-o-xylylene which
undergoes a [4+2] cycloaddition to form the primary photoproduct. Unlike the previous
work that contained both anti- and syn- products, this reaction only produced the anti[4+2] cycloaddition adduct. It is thought that after ESIPT, the formation of the diradical
allows for the in-OH conformation, which is stabilized by intramolecular hydrogen
bonding with the linker. Moreover, in the out-OH there is stabilizing hydrogen bonding
with the solvent, which is assumed to not be as strong as the hydrogen bonding of the
oxalylamides from the anti-OH (Figure 1.16).2

15

Figure 1.16: Anti-diastereoselectivity of the primary photoproduct is
rationalized in by the strong intramolecular H-bonding that
maintains the in-OH conformation.2
(adopted from J. Am. Chem. Soc. 2017, 139, 16584−16590)

This primary photoproduct can then undergo a secondary photochemical reaction,
which is sensitized by the multifunctional tether (Figure 1.17). The photochemical cascade
involves the excitation of the oxalyl anilide chromophore, followed by intersystem crossing
into the triplet state with triplet energy transfer from the dicarbonyl to the cyclohexadiene.
16

After intersystem crossing, the α-hydrogen abstraction and recombination of the two
radical centers completed the formation of the azabicyclo[2.2.2]octene core 1.65.

Figure 1.17: Plausible mechanism for secondary step
(adopted from J. Am. Chem. Soc. 2017, 139, 16584−16590)

Looking at Figure 1.18, it is shown that these short procedures accompanied with
strategic photoprecursor design allows for a considerable increase of complexity after
irradiation and post-photochemical transformations, while using available chemical
feedstock. The Boc-protected p-phenylenediamine and 2-fluoro-nicotinaldehyde are
reacted through reductive animation, then assembled with o-aminoacetophenone with an
oxalyl chloride tether. The photoproduct is acid-catalyzed to form the product 7azaindoline 1.71.
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Figure 1.18: Post-photochemical modification
(adopted from J. Am. Chem. Soc. 2017, 139, 16584−16590)

1.2.5 Light Emitting Diodes (LEDs) with Wavelength (λ) ≈ 365 nm
It is assumed that photochemistry is expensive, messy, and unreliable; however, it
is quite inexpensive, simple, and easy to predict. In the Kutateladze group, it is more
economical to make our own irradiators, which was carried out by a past member. The
power supply used for the reactions is manufactured by RECOM from Mouser at roughly
80 dollars, which gives 142 V and 700 mA. The heat sink has an attached fan for heat
dissipation for the LED array. The LED emitters purchased for the heat sink were 2.9 W
LED Engin LZ4-44UV00, which cost roughly 60 dollars. These LEDs are 18 V and each
irradiator needs 7 of them; providing at least 126 V. The in-house constructed irradiators
can be tedious to build; however, once the arrangement of the irradiators is established, all
future set-ups are simple and efficient. The cost/benefit analysis would show that
photochemistry is a powerful synthetic tool, scientifically and economically.
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Mukhina et al., discovered that azaxylylenes are initiated at wavelengths above 300
nm, with most ranging from 330 nm to 380 nm. The wavelength of our LEDs is 365 nm
because it is the ideal energy to give the least amount of side products with an optimized
conversion rate. Since 330 nm has a higher energy there is an absorption of many side
products which affects the yield of or reaction; moreover, 380 nm is limited by its lower
energy which could affect the conversion of photoprecursor to photoproduct. Ideally, each
photon emitted would hit one atom of photoprecursor; the more photons that are produced,
the faster the reaction. At this point, we are able to make irradiators that specially target
photoactive cores to achieve azaxylylene intermediates, which the Kutateladze lab has
done with 365 nm LED lights.
1.3 Access to Aromatic Polyheterocyclic Architectures
Our goal is to achieve flat, complex poly-heterocycles with minimal steps, which
are easily accessible through cheap chemical feedstock. Though this process was reversed
engineered, we could use the photoreactions previously discovered in the lab to access
these complex architectures. As mentioned before, there are many quinoline-based
compounds used as antimalarial drugs such as: hydroxychloroquine, quinine, and
mefloquine; also, quinacrine which proficiently kills parasites.
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1.3.1 Retrosynthetic Analysis
In order to design “flat” poly-heterocycles, we planned a retrosynthetic route to
target a simple, flat aromatic compound, benzofuro[3,2-b]quinolone 1.72; however, the
post-photochemical transformation would be the most challenging (Figure 1.19).
benzofuro[3,2-b]quinolone 1.72 would be synthesized by the hydrolyzation of
photoproduct 1.73. This photoproduct should be effortlessly synthesized during a
photochemical reaction via aza-o-xylylene, which has been a key component in our lab.
The design of photoprecursor 1.74 uses benzofuran as the unsaturated pendant and
aminobenzaldehyde as the photoactive core, which is tethered by an oxalyl anilide linker
which is accessed via click-like chemistry with aminobenzofuran, oxalyl chloride, and
acetal protected aminobenzaldehyde.
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Figure 1.19: Retrosynthetic route to aromatic-flat polyheterocycles

1.3.2 Synthesis of Photoprecursor, Photoproduct, and Aromatic
Polyheterocycles
Kuznetsov successfully developed a general notion of step-economy around a
multifunctional oxalylamide tether, which improves the physical properties of the
precursor.2 We wanted to exploit the use of this tether and photoactive core for such
reasons: simple procedures are accompanied by an increase of complexity, yields are
good/moderate and, the photoprecursors are highly reactive. We changed the unsaturated
pendant to that of the heterocycle benzofuran, Figure 1.20.
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Figure 1.20: Synthetic route to photoprecursors tethered
by multifunctional oxalylamide

From past research in our lab, it was evident that the amine on the unsaturated
pendant must be protected with benzyl; therefore, we took the methyl 3-aminobenzofuran2-carboxylate 1.78 and under reductive amination conditions with benzaldehyde afforded
product 1.80. This benzyl is necessary for its sterics; it allows for a smaller angle to permit
the proton transfer to occur. The presence of the o-carbonyl in the benzofuran pendant
accelerates the initial attack of the N-radical center of the triplet state azaxylylene on the
π-density of the pendant; thus, all substrates were designed to have o-carbonyl.
Next, the benzyl protected amine of benzofuran was used to synthesize a
nonsymmetric

oxalyl

anilide

photoprecursor

with

oxalyl

chloride

and

2-

aminobenzaldehyde. This linear photoprecursor is designed by amide bond formation
through click-like chemistry, available chemical feedstock, and high yielding coupling
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reactions. This photoprecursor was introduced to a key photochemical step that increases
the molecular complexity, producing unique photoproducts.
When the linear photoprecursor undergoes irradiation, the excited state
intramolecular proton transfer (ESIPT) generates the azaxylylene intermediate, which
undergoes a [4+2] Diels - Alder cycloaddition. This gives us rapid access to complex
nitrogen heterocycles with inserted natural product like moieties (Figure 1.21). These
photoproducts are synthesized via simple and high-yielding reactions, with the
photochemical step offering access to polyaromatic heterocycles containing a quinoline
core.

Figure 1.21: ESIPT generates azaxylylene followed by [4+2] cycloaddition

The post-photochemical transformation is particularly significant because it is not
dependent on the unsaturated pendants and photoactive core. Also, it is not limited to the
elimination of the linker but could also include decarboxylative elimination of the ester
fragments. We determined a two-step process involving a base-catalyzed aromatization of
the phenol-based photoproducts. With the idea to minimize the number of steps, we did the
photochemical reaction and transformation in one pot using the same solvent for both
reactions. After irradiating the photoprecursor in methanol, potassium carbonate was added
to the reaction flask, then the reaction was heated to yield the fully aromatic quinoline 1.89.
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Figure 1.22: Post-photochemical modification

In some cases, when using the strong base sodium methoxide, the photoprecursor
would break apart. We finalized a general procedure with potassium carbonate to base
catalyze the aromatization transformation which gave higher yields; however, the reaction
time increased. Initially when designing the photoprecursor, the oxalyl bridge is used to
accelerate the cycloaddition, but now it has an additional function; it is also used as a
scaffold which is later removed under basic conditions through ester hydrolysis and
decarboxylation, Figure 1.23.

Figure 1.23: Base-induced aromatization of primary photoproducts
via ester hydrolysis and decarboxylation
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1.3.3 Scope of Polyheterocycles through Diversifying the Unsaturated
Pendant and Photoactive Core
With the success of the designed photoprecursors and post-photochemical
transformations, we decided to exploit this efficient methodology to diversify the synthesis
of quinolines. To do so, we wanted a general procedure that could be easily carried out
with high yields, cheap starting materials, simple conditions, and most importantly, extend
the complexity of these quinolines. Note: Yellow represents photoactive core and blue
represents unsaturated pendant

First, we diversified the unsaturated pendant to increase the complexity of the final
product (Figure 1.24). We began with a simple condensation of 2-hydroxybenzonitrile with
methyl bromoacetate and potassium carbonate in DMF which furnished methyl 3aminobenzofuran-2-carboxylate in great yields.9 We also found a simple procedure for 3amino-1-benzothiophene-2-carboxylate, which we later modified to increase the yield. We
decided to use a stronger base, sodium hyrdride, to treat the solution of 2-chlorobenzonitrile
and ethyl thioglycolate in DMF. We changed the conditions from potassium carbonate to
sodium hydride because when we scaled up the reaction, the reaction would not be
completed. Safety considerations for this reaction: skin irritant, severe burns can occur,
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irritate the nose, throat and lungs, flammable, and explosive. When doing this reaction,
there needs to be an outlet for the hydrogen gas to escape; moreover, under nitrogen
atmosphere.

Figure 1.24: Synthesis of methyl 3-aminobenzofuran-2-carboxylate and for
3-amino-1-benzothiophene-2-carboxylate. (Note: Blue represents unsaturated pendant)

Due to the effectiveness of these simple reactions, we were able to scale up to ~ 10
grams and modify the starting materials to 3-cyano-2-hydroxypyridine and 2-chloro-3cyanopyridine which increased the scope of unsaturated pendants.

With proof of concept, we continued to synthesize a variety of substrates (1.105
and 1.106) with easily accessible benzonitriles.
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Knowing that the scope of the reaction has the potential of being wide-ranging, we
also extended the number of heterocycles on the benzonitriles for the synthesis of the
unsaturated pendants (Figure 1.25).

Figure 1.25: Approached to heteroaromatic o-amino carboxylates
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Reaction 1 in Figure 1.25 shows the use of the cheap starting material, 6aminoquinoline-5-carbonitrile, which underwent diazotization then bromination via a
Sandmeyer-type reaction producing 6-bromoquinoline-5-carbonitrile in moderate yields
Looking at Figure 1.25, the formation of the diazonium ion occurred first, then the aromatic
diazo group was substituted with a halogen. 6-bromoquinoline-5-carbonitrile 1.124 reacted
with ethyl thioglycolate under basic conditions in DMF to give us a larger unsaturated
pendant to extend our final modified product.

Figure 1.26: Mechanism of diazotization-bromination of arylamine

Reaction 2 in Figure 1.25 shows the simplicity of the starting materials that can be
used to increase the intricacy of photoprecursor design. This offers rapid access to complex
unsaturated pendants with experimentally simple, high yielding steps. Reaction 3, Figure
1.25 was adopted to continue the scope production of the thiophene unsaturated pendant.
Prasath and Bhavana explained the synthesis of porphyrins using very general procedures,
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which required the use of N-acetyl-1-napthylamine in a Vilsmeier Haack cyclization
(Scheme 1.27). This cyclization elegantly offered access to the desired product 1.112,
which was essential in the production of the complex thiophene unsaturated pendant.

Figure 1.27: Mechanism of Vielsmeier Haack Reaction

Product 1.112 was converted from the aldehyde to the nitrile product in the
presence of ammonium acetate, sodium carbonate, iodine, and tert-Butyl hydroperoxide.
We

were

able

to

successfully

synthesize

the

desired

product

ethyl

8-

aminobenzo[h]thieno[2,3-b]quinoline-9-carboxylate 1.114.
We also continued the scope with the benzofuran moiety, which was extended by
an additional benzene ring. 2-hydroxy-1-naphthaldehyde was first reacted with triflic acid
to protect the alcohol, then trimethylsilyl azide was used to change the aldehyde to a nitrile
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group in high yields (Figure 1.25). Next, product 1.116 reacted with methyl bromoacetate
in basic conditions to afford product 1.117, which could be used as an unsaturated pendant.
We simply constructed 2D mini-libraries to prepare the unsaturated pendant to
attach the oxalyl chloride through common intermediates. Next, using the similar building
block notion, we targeted suitable photoactive cores to build onto the oxalyl bridge. With
proof of concept, we were able to successfully construct photoprecursor 1.151 in high
yields with 2-Amino-3-pyridinecarboxaldehyde as the photoactive core, Figure 1.28.

Figure 1.28: 3-step construction to aromatic polyheterocycle with
amino-pyridine carbaldehyde as photoactive core.

Unfortunately, the yield of the photoprecursor was low due to some of the precursor
undergoing a [4+2] Diels-Alder cycloaddition in the ground state. However, the reaction
does not complete in the ground state and with our simple construction of the
photoprecursor, we are able to take the unpurified mixture, dissolve it in methanol and
irradiate; luckily, the ground state product does not decompose during this process. With
this crude methanol mixture, potassium carbonate was added, and the reaction was heated
to yield product 1.153.
Figure 1.29 shows the synthesis of the photoactive core, 2-aminoquinoline-3carbaldehyde 1.156, in two simple steps which could be generally used to make most of
the future photoactive cores. We figured that if we were able to synthesize amino30

benzonitriles, we could easily reduce the nitriles into aldehydes with Raney nickel and
formic acid.

Figure 1.29: Synthesis of aminobenzonitriles, then reduction to
aldehydes to produce photoactive core. (Note: yellow represent photoactive core)

Scaffold diversity was implemented with both the synthetically useful design of the
photoactive core and unsaturated pendant. The idea was to start with ~10-20 grams of 2amino-3-formylpyridine, which goes for roughly 25g for $85. As mentioned before, the
ring could be extended with malanonitrile and then reduced with Raney nickel, which could
be taken a step further as seen in Figure 1.30. This reaction must be done with caution;
self-heating may catch the Raney Ni on fire and is suspect to cause cancer. When doing
this reaction, the reaction flask must be heated with all reagents in the flask and the heat
should gradually increase. Also, the reaction should not be left overnight/alone in case of
a fire.
The idea is to use inexpensive chemical feedstock in a multi-gram scale to target
specific architectures with high yields. With a basic understanding of the schematics, these
reactions should be straightforward and suitable to use in drug design. However, the use of
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photochemistry allows access to complex aromatic polyheterocycles, which could not be
obtained with simple-straight forward reactions.

Figure 1.30: Straightforward approach synthesis of “building blocks”
to afford complex photoprecursors. (Note: yellow represent photoactive core)

All the reactions used for the synthesis of the unsaturated pendants and photoactive
cores aided to the tailoring of the photoprecursors, which were constructed like buildingblocks. The unsaturated pendant and photoactive core can be specifically designed to
eventually target the flat/fully aromatic heterocycle. Looking at Figure 1.31, we thought
that the substrate used as the unsaturated pendant could in fact be transformed into a
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photoactive core in two steps. But this circumstance would assume that the photoactive
core could be a 5-membered ring, thiophene.

Figure 1.31: Synthesis of photoactive core from unsaturated pendant

To test this concept, we synthesized a photoprecursor with benzofuran as the
pendant knowing that the photochemistry is dependent on the photoactive core, 3aminothiophene-2-carbaldehyde

1.163

(Figure

1.32).

After

irradiation

of

the

photoprecursor 1.164 and the post-photochemical transformation of 1.165, we were able
to successful isolate and characterize thienopyridine 1.166, which has never been
synthesized before.

Figure 1.32: Successful synthesis of final molecule
via a 5-membered photoactive core

Also, we were able to successfully extend the photoactive core to increase the size
of the polyheteocycles, Figure 1.33. This was a perfect example of tailoring the
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photoprecursors to lengthen the final products. Also, we were able to synthesize these
photoactive cores and unsaturated pendants in a multigram scale with high yields.

Figure 1.33 Tailoring photoprecursor to target elongated polyheterocycles.
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1.3.4 Scope of photoprecursors, photoproducts, and post-photochemical modification products

35
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Table 1: Scope of flat-aromatic polyheterocyclic compounds

1.3.5 Conclusion
Understanding intramolecular cycloaddition of azaxylylenes allows the access to
other derivatives of these complex quinolines. Also, the awareness of intermediates
photogenerated via excited state intramolecular proton transfer helps implement [4+2]
cycloadditions. The modifications of the photoproducts through base catalyzed methods,
built a foundation in targeting other structures. Moreover, the sp2-sp2 coupling, amide
bond formation, and click-like chemistry were used to develop high yielding linear
photoprecursors. Photoinduced cycloadditions on these linear photoprecursors folded into
three-dimensional photoproducts. As a result, these primary photoproducts can undergo a
post-chemical transformation to increase scaffold complexity, diversity inputs, and
exploit reactivity. With our ability to use this critical photochemical step, we displayed
diversity of products that can be synthesized.
We have a general synthetic route in assembling photoprecursors that undergo
photoinduced cycloaddition. Aromatic amino-aldehydes or ketones are able to undergo
[4+2] cycloadditions with a variety of unsaturated pendants and photoactive cores to form
photoprecursors; as a result, azaxylylenes can be photogenerated by these
photoprecursors which can undergo a post-photochemical transformation to form new
compounds that can be used in drug discovery.
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1.4 Experimental
1.4.1 General Methods
Common solvents were purchased from Fisher Scientific and used as is, except for THF,
which was refluxed over and distilled from sodium benzophenone ketyl prior to use.
Common reagents were purchased from Sigma-Aldrich, TCI America, AK Scientific,
Oakwood Chemical or AstaTech and used without additional purification. NMR spectra
were recorded at 25 °C on a Bruker Avance III 500 MHz instrument in CDCl3 with TMS
as an internal standard (unless noted otherwise). High resolution mass spectra were
obtained on a Waters Synapt G2 HDMS Quadrupole/ToF mass spectrometer with
electrospray ionization (Central Analytical Laboratory, University of Colorado Boulder)
by Dmitry Kuznetsov and Dr. D. Sai Reddy. Flash column chromatography was performed
using Teledyne Isco RediSep® Rf Normal Phase Silica Gel (230– 400 mesh or 400–632
mesh) on a Teledyne Isco CombiFlash® Rf 200 instrument. X-ray structures were obtained
with a Bruker SMART APEX II diffractometer (for details see page S36 and included CIF
files).
Reductive animation (General procedure A)

Primary amines (2.4 mmol) were dissolved in anhydrous DCM (25 mL).
Benzaldehyde (3.6 mmol) and molecular sieves 4Å were added, and the mixture was stirred
at ambient temperature until completion (monitored by 1H NMR). Solids were filtered off
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and washed with DCM. The filtrate was concentrated in vacuo. The residue was dissolved
in absolute methanol (20 mL), sodium cyanoborohydride (0.15 g, 2.4 mmol) was added at
0 °C, and the mixture was stirred overnight. Upon completion (as indicated by 1H NMR),
methanol was evaporated, the residue was partitioned between ethyl acetate (100 mL) and
water (15 mL). The organic layer was separated, washed with water (2x10 mL) and brine
(10 mL), dried over anhydrous Na2SO4, and the solvent was removed under reduced
pressure to afford secondary anilines. The majority of products were purified by flash
chromatography on silica gel.

Dibenzylation (General Procedure B)

Primary indole amines (2.6 mmol) in DMF (10 mL) were added dropwise to a
stirring solution of NaH (60w% dispersion in mineral oil 0.32 g, 8.0 mmol) in DMF (10
mL) at 0oC under nitrogen. After 10 minutes of stirring, benzyl bromide (0.94 mL, 5.4
mmol) in DMF (20 mL) was added dropwise. The reaction was left overnight at room
temperature. Upon completion (as indicated by 1H NMR), the reaction was quenched with
water (20mL) at 0 oC, and the reaction mixture was partitioned between ethyl acetate (100
mL) and water (20 mL). The organic layer was separated, washed with water (2x10 mL),
dried over anhydrous Na2SO4, and the solvent was removed under reduced pressure to
afford secondary anilines. The majority of products were purified by flash chromatography
on silica gel.
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Coupling of secondary anilines with photoactive cores (dioxolane-protected) via oxalyl
linker (General procedure C)
A solution of secondary aniline (1.0 mmol) in anhydrous DCM (10 mL) was
quickly poured into a solution of oxalyl chloride (0.84 mL, 1.3 g, 10.0 mmol) in anhydrous
DCM (10 mL) with vigorous stirring (note: slow addition may lead to formation of bisoxalyl amide), and the mixture was stirred at ambient temperature until completion
(monitored by 1H NMR). Volatiles were removed under reduced pressure, and the residue
was redissolved in anhydrous DCM (10 mL) under nitrogen. A solution of dioxolaneprotected primary aniline (1.1 mmol) and DIPEA (0.35 mL, 0.26 g, 2.0 mmol) in anhydrous
DCM (10 mL) was added dropwise at 0 °C under nitrogen. The mixture was stirred at
ambient temperature overnight, and then it was diluted with DCM (40 mL) and washed
with water (3x10 mL). The combined organic layer was dried over anhydrous Na2SO4, and
the solvent was removed in vacuo. Photoprecursors were purified by flash chromatography
on silica gel.

Coupling of secondary anilines with photoactive cores via oxalyl linker
(General procedure D)
A solution of secondary aniline (1.0 mmol) in anhydrous DCM (10 mL) was
quickly poured into solution of oxalyl chloride (0.84 mL, 1.3 g, 10.0 mmol) in anhydrous
DCM (10 mL) with vigorous stirring (note: slow addition may lead to formation of bisoxalyl amide), and the mixture was stirred at ambient temperature until completion
(monitored by 1H NMR). Volatiles were removed under reduced pressure, and the residue
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was redissolved in anhydrous DCM (10 mL) under nitrogen. A solution of 2-amino-3formylpyridine (1.1 mmol) and DIPEA (0.35 mL, 0.26 g, 2.0 mmol) in anhydrous DCM
(10 mL) was added dropwise at 0 °C under nitrogen. The mixture was stirred at 0 °C for
one hour and then it was diluted with DCM (40 mL) and washed with water (3x10 mL).
The combined organic layer was dried over anhydrous Na2SO4, and the solvent was
removed in vacuo. Photoprecursors were purified by flash chromatography on silica gel.

Dioxolane deprotection (General procedure E)
The dioxolane-protected photoprecursor (1.89 mmol) was dissolved in acetone (15
mL), p-TsOH·H2O (0.107 g, 0.567 mmol) was added, and the mixture was stirred at
ambient temperature for 1 day. The solvent was removed in vacuo, and the residue was
dissolved in DCM (50 mL). The solution was washed with sat. aq. NaHCO3 (2x10 mL)
and with water (10 mL). The combined organic layers were dried over anhydrous Na2SO4,
and the solvent was removed in vacuo. Further purification by flash chromatography on
silica gel yielded aldehyde-based photoprecursors.

Cyclization of hydroxynitriles to furans (General procedure F)

A suspension of the appropriate hydroxybenzonitrile (1.0 equiv), methyl
bromoacetate (1.2 equiv), and K2CO3 (2 equiv) in DMF (10 mL) was stirred at 60 °C for 4
h until consumption of the limiting reagent, followed by reflux heating for 8 h. The reaction
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mixture was cooled to ambient temperature and filtered through Celite. Then the filtrate
was evaporated in vacuo. The residue was dissolved with ethyl acetate (30 mL), and the
solution was washed sequentially with water (10 mL) and brine (10 mL). The organic layer
was dried, filtered, and concentrated under reduced pressure, and the residue was purified
by flash column chromatography on silica gel (hezanes à ethyl acetate; 8:2).

Base promoted aromatization (General procedure G)
Photoprecursor (0.5 mmol) was irradiated according to General Procedure F. The
photoproduct in solution was transferred into a round bottom flask with K2CO3 (1.1 mmol).
This solution was refluxed and stirred at 75 °C until completion (monitored by 1H NMR).
Volatiles were evaporated under reduced pressure, and the residue was redissolved in DCM
(15 mL). Solution was washed 2 times with water (5 mL). Aqueous layer was extracted
with DCM (2x10 mL). The combined organic layer was washed with water (10 mL) and
brine (10 mL), dried over anhydrous Na2SO4, and the solvent was removed in vacuo.
Further purification by flash chromatography on silica gel yielded modified photoproducts
in 43-88% yields (after two steps).
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1.4.2 Synthesis of Unsaturated Pendants

ethyl 3-(benzylamino)benzofuran-2-carboxylate (1.171): General procedure A was
followed on a (0.95 g, 5.0 mmol, 1 equiv.) scale of ethyl-3-aminobenzofuran-2-carboxylate
with (0.80 mL, 7.5 mmol, 1.5 equiv.) benzaldehyde in 50 mL of anhydrous DCM. The
resulting imine was then reduced with (0.31 g, 5.0 mmol, 1 equiv.) sodium
cyanoborohydride in 50 mL of absolute methanol according to the same general procedure;
which after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl
acetate 4:1) afforded 1.25 g (58 %) of the title compound as light yellow solid. 1H NMR
(500 MHz, Chloroform-d) δ 7.58 (dt, J = 7.9, 1.0 Hz, 1H), 7.52 – 7.45 (m, 2H), 7.43 – 7.37
(m, 4H), 7.38 – 7.30 (m, 1H), 7.30 – 7.23 (m, 2H), 4.73 (s, 2H), 4.47 (q, J = 7.1 Hz, 2H),
1.47 (t, J = 7.1 Hz, 3H).

ethyl 3-(benzylamino)furo[2,3-b]pyridine-2-carboxylate (1.172): General procedure A
was followed on a (0.49 g, 2.6 mmol, 1 equiv.) scale of ethyl 3-aminofuro[2,3-b]pyridine2-carboxylate with (0.42 mL, 4.0 mmol, 1.5 equiv.) benzaldehyde in 50 mL of anhydrous
DCM. The resulting imine was then reduced with (0.16g, 2.6 mmol, 1 equiv) sodium
cyanoborohydride in 50 mL of absolute methanol according to the same general procedure;
which after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl
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acetate 4:1) afforded 0.50 g (68 %) of the title compound as light yellow solid. 1H NMR
(500 MHz, Chloroform-d) δ 8.46 (dd, J = 4.8, 1.7 Hz, 1H), 8.00 (dd, J = 7.9, 1.7 Hz, 1H),
7.47 – 7.30 (m, 5H), 7.13 (dd, J = 7.9, 4.8 Hz, 1H), 6.67 (s, 1H), 4.85 (d, J = 6.5 Hz, 2H),
4.45 (q, J = 7.1 Hz, 2H), 1.45 (t, J = 7.1 Hz, 3H).

methyl 3-(benzylamino)benzo[b]thiophene-2-carboxylate (1.173): General procedure
A was followed on a (0.49 g, 2.4 mmol, 1 equiv.) scale of methyl 3-amino-1benzothiophene-2-carboxylate with (0.38 mL, 3.6 mmol, 1.5 equiv.) benzaldehyde in 50
mL of anhydrous DCM. The resulting imine was then reduced with (0.15 g, 2.4 mmol, 1
equiv.) sodium cyanoborohydride in 50 mL of absolute methanol according to the same
general procedure; which after flash chromatography on silica gel (gradient elution: hexane
→ hexane–ethyl acetate 4:1) afforded 0.40 g (59 %) of the title compound as yellow-brown
liquid. 1H NMR (500 MHz, Chloroform-d) δ 8.01 (dt, J = 8.3, 0.9 Hz, 1H), 7.74 (dt, J =
8.0, 0.9 Hz, 1H), 7.52 – 7.36 (m, 5H), 7.34 – 7.22 (m, 3H), 4.97 (s, 2H), 3.89 (s, 3H).

ethyl 3-(benzylamino)thieno[2,3-b]pyridine-2-carboxylate (1.174): General procedure
A was followed on a (0.87 g, 4.5 mmol, 1 equiv.) scale of ethyl 3-aminothienopyridine-2carboxylate with (5.9 mmol, 1.3 equiv.) benzaldehyde in 50 mL of anhydrous DCM. The
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resulting imine was then reduced with (0.28 g, 4.5 mmol, 1 equiv.) sodium
cyanoborohydride in 50 mL of absolute methanol according to the same general procedure,
which after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl
acetate 4:1) afforded 0.74 g (57 %) of the title compound as a light-yellow solid. 1H NMR
(500 MHz, Chloroform-d) δ 12.62 (s, 1H), 10.03 (d, J = 0.7 Hz, 1H), 8.71 (dd, J = 4.6, 1.6
Hz, 1H), 8.37 (d, J = 8.4 Hz, 1H), 7.71 (ddd, J = 18.5, 7.9, 1.7 Hz, 2H), 7.49 (ddd, J = 8.8,
7.4, 1.6 Hz, 1H), 7.29 (d, J = 4.9 Hz, 1H), 7.28 – 7.17 (m, 6H), 5.03 (s, 2H), 4.16 (dq, J =
10.9, 7.2 Hz, 1H), 4.02 (dq, J = 10.8, 7.1 Hz, 1H), 1.23 (t, J = 7.1 Hz, 3H). 13C NMR (126
MHz, CDCl3) δ 194.70, 161.95, 161.20, 159.01, 158.19, 150.02, 138.84, 136.19, 135.97,
135.73, 135.15, 131.09, 130.12, 130.07, 128.40, 128.32, 127.47, 124.02, 122.74, 120.39,
119.96, 62.11, 54.38, 13.92.
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1.4.3 Synthesis of Photoprecursors

ethyl

3-(N-benzyl-2-(2-formylphenylamino)

oxoacetamido)benzofuran-2-carboxylate (1.1a):

–

2

-

(0.070 g,

0.34 mmol, 1 equiv.) of the secondary aniline 1.171 was coupled
with oxalyl chloride (3.6 mmol, 10 equiv.), and the resulting oxalyl chloride was coupled
with 2-(1,3-dioxolan-2-yl)aniline (0.06 g, 0.36 mmol, 1.2 equiv.) by General procedure C;
affording 0.165 g (89 %). Dioxolane protection was then removed according to general
procedure E with (0.01 g, 0.064 mmol, 0.02 equiv.) p-TsOH·H2O; which after flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 7:3)
afforded 0.10 g (67 %) of the title compound as white solid.1H NMR (500 MHz,
Chloroform-d) δ 12.54 (s, 1H), 10.03 (d, J = 0.7 Hz, 1H), 8.44 (d, J = 8.5 Hz, 1H), 7.73
(dd, J = 7.6, 1.6 Hz, 1H), 7.62 (dt, J = 8.5, 0.8 Hz, 1H), 7.51 (dddd, J = 8.8, 7.2, 4.6, 1.5
Hz, 2H), 7.45 (dt, J = 7.9, 1.2 Hz, 1H), 7.33 (ddd, J = 8.0, 7.1, 0.9 Hz, 1H), 7.29 (s, 1H),
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7.28 – 7.24 (m, 5H), 5.24 (d, J = 13.9 Hz, 1H), 4.91 (d, J = 14.0 Hz, 1H), 4.15 (dq, J = 10.7,
7.1 Hz, 1H), 3.98 (dq, J = 10.8, 7.1 Hz, 1H), 1.17 (t, J = 7.2 Hz, 3H).13C NMR (126 MHz,
CDCl3) δ 194.8, 162.3, 158.5, 158.3, 153.9, 139.3, 139.0, 136.0, 135.8, 135.2, 129.8,
129.3, 128.3, 128.3, 128.2, 124.6, 124.3, 124.0, 122.6, 120.7, 120.0, 112.9, 77.3, 77.0, 76.8,
61.7, 53.8, 13.8. HRMS (ESI) calcd for C27H23N2O6 + (MH+) 471.1556, found 471.1564

ethyl-3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2oxoacetamido)benzofuran-2-carboxylate (1.2a):
(0.09 g, 0.45 mmol, 1 equiv.) of the secondary aniline 1.171 was
coupled with oxalyl chloride (0.38 mL, 4.5 mmol, 10 equiv.), and the resulting acyl
chloride was coupled with 3-Amino-pyridine-2-carbaldehyde (0.06 mL, 0.5 mmol, 1.1
equiv.) according to General Procedure D; which after flash chromatography on silica gel
(gradient elution: hexane → hexane–ethyl acetate 1:4) afforded 0.15 g (71 %) of the title
compound as a yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 12.40 (s, 1H), 10.18
(d, J = 0.7 Hz, 1H), 8.78 (dt, J = 8.6, 1.1 Hz, 1H), 8.51 (dd, J = 4.5, 1.4 Hz, 1H), 8.15 (dd,
J = 4.2, 1.3 Hz, 1H), 7.62 (dt, J = 8.4, 0.8 Hz, 1H), 7.53 (ddd, J = 8.5, 7.1, 1.3 Hz, 1H),
7.44 (ddd, J = 8.0, 1.3, 0.7 Hz, 1H), 7.40 (ddd, J = 8.7, 4.4, 0.6 Hz, 1H), 7.34 (ddd, J = 7.9,
7.1, 0.9 Hz, 1H), 7.26 (s, 3H), 7.06 (ddd, J = 8.5, 1.4, 0.7 Hz, 1H), 5.25 (d, J = 13.9 Hz,
1H), 4.90 (d, J = 13.9 Hz, 1H), 4.16 (dd, J = 10.8, 7.2 Hz, 1H), 4.09 – 3.90 (m, 1H), 1.18
(t, J = 7.2 Hz, 4H). 13C NMR (126 MHz, CDCl3) δ 196.8, 161.8, 158.8, 158.4, 153.9,
146.2, 145.3, 139.5, 139.3, 138.1, 136.5, 135.0, 134.8, 129.8, 129.1, 128.4, 127.6, 124.4,
124.2, 120.6, 113.0, 61.7, 53.8, 13.9.
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ethyl-3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2oxoacetamido)benzofuran-2-carboxylate (1.3a): (0.22 g, 1.1
mmol, 1 equiv.) of the secondary aniline 1.171 was coupled with
oxalyl chloride (0.94 mL, 11.0 mmol, 10 equiv.), and the resulting acyl chloride was
coupled with 2-amino-3-formylpyridine (0.13 g, 1.1 mmol, 1 equiv.) according to General
Procedure D; which after flash chromatography on silica gel (gradient elution: hexane →
hexane–ethyl acetate 1:4) afforded 0.43 g (83%) of the title compound as white solid.
HRMS (ESI) calcd for C27H23N2O6 + (MH+) 471.1556, found 471.1563

methyl-3-(N-benzyl-2-(3-formylbenzo[h]quinolin-2ylamino)-2-oxoacetamido)benzofuran-2-carboxylate
(1.4a): (0.26 g, 1.35 mmol, 1 equiv.) of the secondary aniline
1.171 was coupled with oxalyl chloride (1.2 mL, 13.5 mmol,
10 equiv.), and the resulting acyl chloride was coupled with 2-aminobenzo[h]quinoline-3carbaldehyde (0.23 mmol, 1 equiv.) according to General Procedure D; which after flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 1:4)
afforded 0.31 g (40 %) of the title compound as white solid. Note that there are impurities
after purification and this is due to small amounts of the ground state 4+2 cycloaddition
product. This has also affected the yield.
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methyl-3-(N-benzyl-2-(3-formylquinolin-2-ylamino)-2oxoacetamido)benzofuran-2-carboxylate (1.5 a): 1. (0.13 g,
0.68 mmol, 1 equiv.) of the secondary aniline 1.171 was coupled
with oxalyl chloride (0.58 mL, 6.8 mmol, 10 equiv.), and the
resulting acyl chloride was coupled with 2-Amino-3-quinolinecarboxaldehyde (0.15 g,
0.68 mmol, 1 equiv.) according to General Procedure D; which after flash chromatography
on silica gel (gradient elution: hexane → hexane–ethyl acetate 1:4) afforded 0.11 g (32 %)
of the title compound as white solid. Note that there are impurities after purification and
this is due to small amounts of the ground state 4+2 cycloaddition product. This has also
affected the yield.

methyl-3-(N-benzyl-2-(2-formylthiophen-3-ylamino)-2oxoacetamido)benzofuran-2-carboxylate (1.6a): (0.22 g, 1.14
mmol, 1 equiv.) of the secondary aniline was coupled with
oxalyl chloride (0.98 mL, 11.4 mmol, 10 equiv.), and the resulting acyl chloride was
coupled with 3-aminothiophene-2-carbaldehyde (0.14 g, 1.14 mmol, 1 equiv.) according
to General Procedure D (Note: the reaction was quenched after 2 hours); which after flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 1:4)
afforded 0.18 g (34 %) of the title compound as yellow solid. Note that there are impurities
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after purification and this is due to small amounts of the ground state 4+2 cycloaddition
product. This has also affected the yield.

ethyl-3-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)furo[2,3-b]pyridine-2-carboxylate

(1.8a):

(0.070 g, 0.34 mmol, 1 equiv.) of the secondary aniline 1.172 was
coupled with oxalyl chloride (0.29 g, 3.4 mmol, 10 equiv.), and the resulting acyl chloride
was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.056 g, 0.34 mmol, 1 equiv.) by General
procedure C, affording 0.13 g (76 %). Dioxolane protection was then removed according
to general procedure E with (0.013 g, 0.075 mmol, 0.22 equiv.) p-TsOH·H2O; which after
flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 7:3)
afforded 0.09 g (76 %) of the title compound as white solid. 1H NMR (500 MHz,
Chloroform-d) δ 12.56 (s, 1H), 10.02 (s, 1H), 8.53 (dd, J = 4.8, 1.7 Hz, 1H), 8.39 (d, J =
8.4 Hz, 1H), 7.74 (dd, J = 7.7, 1.7 Hz, 1H), 7.57 (dd, J = 7.8, 1.7 Hz, 1H), 7.52 (ddd, J =
8.7, 7.4, 1.6 Hz, 1H), 7.33 – 7.26 (m, 3H), 7.26 – 7.24 (m, 4H), 5.20 (d, J = 14.0 Hz, 1H),
4.91 (d, J = 14.0 Hz, 1H), 4.24 (dq, J = 10.7, 7.2 Hz, 1H), 4.13 (dq, J = 10.8, 7.2 Hz, 1H),
1.25 (t, J = 7.1 Hz, 3H).13C NMR (126 MHz, CDCl3) δ 194.8, 162.1, 159.5, 158.2, 158.0,
148.5, 138.8, 138.7, 136.0, 135.8, 135.2, 130.6, 129.7, 128.6, 128.5, 128.4, 124.1, 122.7,
120.6, 119.9, 117.6, 62.0, 53.9, 13.9. HRMS (ESI) calcd for C26H22N3O6 + (MH+)
472.1508, found 472.1514
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ethyl-3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2oxoacetamido)furo[2,3-b]pyridine-2-carboxylate

(1.9a):

(0.16 g, 0.85 mmol, 1 equiv.) of the secondary aniline 1.172
was coupled with oxalyl chloride (0.73 mL, 8.5 mmol, 10
equiv.), and the resulting acyl chloride was coupled with 2-amino-3-formylpyridine (0.10
mL, 0.85 mmol, 1 equiv.) according to General procedure D; which after flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 1:4)
afforded 0.13 g (45%) of the title compound as white solid. Note: most did a ground state
[4+2], not allowing me to get pure compound of the photoprecursor to characterize.

methyl-3-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)benzo[b]thiophene-2-carboxylate (1.10a):
(0.19 g, 0.91 mmol, 1 equiv.) of the secondary aniline 1.173
was coupled with oxalyl chloride (0.78 mL, 9.1 mmol, 10 equiv.), and the resulting acyl
chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.15 g, 0.91 mmol, 1 equiv.)
General procedure C affording 0.38 g (79 %). Dioxolane protection was then removed
according to general procedure E with (0.01 g, 0.075 mmol, 0.08 equiv.) p-TsOH·H2O,
which after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl
acetate 7:3) afforded 0.28 g (83 %) of the title compound as white solid. 1H NMR (500
MHz, Chloroform-d) δ 12.54 (s, 1H), 10.02 (s, 1H), 8.39 (d, J = 8.5 Hz, 1H), 7.87 (dd, J =
8.1, 0.9 Hz, 1H), 7.71 (dd, J = 7.6, 1.6 Hz, 1H), 7.65 (dt, J = 8.1, 1.0 Hz, 1H), 7.53 (ddd, J
= 8.2, 7.1, 1.2 Hz, 1H), 7.45 (dddd, J = 15.2, 8.1, 7.2, 1.3 Hz, 2H), 7.27 – 7.21 (m, 4H),
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7.19 (dd, J = 8.1, 1.7 Hz, 2H), 5.40 (d, J = 13.7 Hz, 1H), 4.70 (d, J = 13.7 Hz, 1H), 3.53 (s,
3H).13C NMR (126 MHz, CDCl3) δ 194.7, 162.3, 161.8, 158.5, 139.0, 138.5, 138.0, 135.9,
135.6, 135.2, 130.2, 128.2, 128.1, 127.7, 127.0, 125.4, 123.8, 123.2, 123.1, 122.7, 120.1,
77.3, 77.0, 76.8, 53.9, 52.2. HRMS (ESI) calcd for C26H20N2O5S + (MH+) 474.1124, found
474.1119.

methyl-3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2oxoacetamido)benzo[b]thiophene-2-carboxylate (1.11 a):
(0.07 g, 0.34 mmol, 1 equiv.) of the secondary aniline 1.173
was coupled with oxalyl chloride (0.29 mL, 3.4 mmol, 10
equiv.), and the resulting acyl chloride was coupled with 3-Amino-pyridine-2carbaldehyde (0.05 g, 0.37 mmol, 1.1 equiv.) according to General procedure D; which
after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate
1:4) afforded 0.13 g (81 %) of the title compound as yellow solid. 1H NMR (500 MHz,
Chloroform-d) δ 12.38 (s, 1H), 10.18 (s, 1H), 8.73 (d, J = 8.7 Hz, 1H), 8.48 (d, J = 4.4 Hz,
1H), 7.87 (d, J = 8.2 Hz, 1H), 7.63 (d, J = 8.1 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 7.43 (t, J
= 7.6 Hz, 1H), 7.35 (dd, J = 8.7, 4.5 Hz, 1H), 7.26 – 7.22 (m, 3H), 7.18 (d, J = 6.6 Hz, 2H),
5.38 (d, J = 13.7 Hz, 1H), 4.74 (d, J = 13.7 Hz, 1H), 3.56 (s, 3H).

ethyl-3-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)thieno[2,3-b]pyridine-2-carboxylate
(1.12a): (0.09 g, 0.39 mmol, 1 equiv.) of the secondary
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aniline 1.174 was coupled with oxalyl chloride (0.33 mL, 3.9 mmol, 10 equiv.), and the
resulting acyl chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.06 g, 0.39 mmol,
1 equiv.) by General procedure C affording 0.18 g (91 %). Dioxolane protection was then
removed according to general procedure E with (0.10 g, 0.07 mmol, 0.18 equiv.) pTsOH·H2O, which after flash chromatography on silica gel (gradient elution: hexane →
hexane–ethyl acetate 7:3) afforded 0.156 g (92 %) of the title compound as light yellow
solid. 1H NMR (500 MHz, Chloroform-d) δ 12.54 (s, 1H), 10.02 (s, 1H), 8.39 (d, J = 8.5
Hz, 1H), 7.87 (dd, J = 8.1, 0.9 Hz, 1H), 7.71 (dd, J = 7.6, 1.6 Hz, 1H), 7.65 (dt, J = 8.1, 1.0
Hz, 1H), 7.53 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.45 (dddd, J = 15.2, 8.1, 7.2, 1.3 Hz, 2H),
7.27 – 7.21 (m, 4H), 7.19 (dd, J = 8.1, 1.7 Hz, 2H), 5.40 (d, J = 13.7 Hz, 1H), 4.70 (d, J =
13.7 Hz, 1H), 3.53 (s, 3H).13C NMR (126 MHz, CDCl3) δ 194.7, 162.3, 161.8, 158.5,
139.0, 138.5, 138.0, 135.9, 135.6, 135.2, 130.2, 128.2, 128.1, 127.7, 127.0, 125.4, 123.8,
123.2, 123.1, 122.7, 120.1, 77.3, 77.0, 76.8, 53.9, 52.2. HRMS (ESI) calcd for
C25H20N3O5S + (MH+) 474.1124, found 474.1127.

ethyl-3-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)thieno[2,3-c]pyridine-2-carboxylate (1.13a):
(0.055 g, 0.25 mmol, 1 equiv.) of the secondary aniline 1.174
was coupled with oxalyl chloride (0.21 g, 2.5 mmol, 10
equiv.), and the resulting acyl chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.05
g, 0.28 mmol, 1.1 equiv.) by General procedure C affording 0.07 g (53 %). Dioxolane
protection was then removed according to general procedure E with (0.005 g, 0.03 mmol,
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0.12 equiv.) p-TsOH·H2O, which after flash chromatography on silica gel (gradient
elution: hexane → hexane–ethyl acetate 7:3) afforded 0.06 g (95 %) of the title compound
as white solid. 1H NMR (500 MHz, Chloroform-d) δ 12.68 (s, 1H), 10.03 (s, 1H), 9.22 (s,
1H), 8.52 (d, J = 5.6 Hz, 1H), 8.34 (d, J = 8.5 Hz, 1H), 7.73 (dd, J = 7.6, 1.8 Hz, 1H), 7.49
(t, J = 7.9 Hz, 1H), 7.40 (d, J = 5.7 Hz, 1H), 7.28 – 7.26 (m, 2H), 7.23 (t, J = 7.5 Hz, 2H),
7.16 (d, J = 7.8 Hz, 2H), 5.16 (d, J = 13.8 Hz, 1H), 4.92 (d, J = 13.7 Hz, 1H), 4.20 – 4.09
(m, 1H), 4.04 – 3.96 (m, 1H), 1.22 (td, J = 7.2, 1.3 Hz, 3H). 13C NMR (126 MHz, CDCl3)
δ 194.7, 161.6, 160.7, 157.9, 144.8, 142.6, 142.3, 138.7, 137.4, 136.0, 135.7, 134.8, 134.1,
133.0, 130.1, 128.5, 124.2, 122.8, 120.4, 119.9, 117.1, 62.5, 54.3, 13.9.

ethyl-3-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)thieno[3,2-b]pyridine-2-carboxylate (1.14a): (0.1
g, 0.45 mmol, 1 equiv.) of the secondary aniline was coupled with
oxalyl chloride (0.39 mL, 4.5 mmol, 10 equiv.), and the resulting
acyl chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.07 g, 0.45 mmol, 1 equiv.) by
General procedure C affording 0.19 g (87 %). Dioxolane protection was then removed according
to general procedure E with (0.01 g, 0.07 mmol, 0.15 equiv.) of p-TsOH·H2O, which after flash

chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 7:3)
afforded 0.13 g (68 %) of the title compound as white solid. 1H NMR (500 MHz, CDCl3)
δ 12.69 (s, 1H), 10.03 (s, 1H), 9.22 (s, 1H), 8.51 (d, J = 5.4 Hz, 1H), 8.34 (d, J = 8.5 Hz,
1H), 7.73 (d, J = 7.6 Hz, 1H), 7.49 (t, J = 7.9 Hz, 1H), 7.40 (d, J = 5.5 Hz, 1H), 7.28 – 7.19
(m, 4H), 7.16 (d, J = 7.4 Hz, 2H), 5.15 (d, J = 13.8 Hz, 1H), 4.92 (d, J = 13.8 Hz, 1H), 4.16
(dq, J = 10.9, 7.2 Hz, 1H), 4.00 (dq, J = 10.6, 7.2 Hz, 1H), 1.22 (t, J = 7.1 Hz, 3H).
53

ethyl-3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2oxoacetamido)thieno[2,3-b]pyridine-2-carboxylate
(1.15a): (0.09 g, 0.42 mmol, 1 equiv.) of the secondary
aniline was coupled with oxalyl chloride (0.36 mL, 4.2
mmol, 10 equiv.), and the resulting acyl chloride was coupled with 3-Amino-pyridine-2carbaldehyde (0.06 g, 0.46 mmol, 1.1 equiv.) according to General procedure D; which
after flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate
1:4) afforded 0.14 g (68 %) of the title compound as yellow solid.

ethyl-8-(N-benzyl-2-(2-formylphenylamino)-2oxoacetamido)benzo[h]thieno[2,3-b]quinoline-9carboxylate (1.18a): (0.12 g, 0.39 mmol, 1 equiv.) of the
secondary aniline 6d was coupled with oxalyl chloride (0.33
mL, 3.9 mmol, 10 equiv.), and the resulting acyl chloride was coupled with 2-(1,3dioxolan-2-yl)aniline (0.06 g, 0.39 mmol, 1 equiv.) by General procedure C affording
0.081 g (35%). Dioxolane protection was then removed according to general procedure E
with (0.07 mmol, 0.2 equiv.) of p-TsOH·H2O, which after flash chromatography on silica
gel (gradient elution: hexane → hexane–ethyl acetate 7:3) afforded 0.03 g (39 %) of the
title compound as white solid. 1H NMR (500 MHz, CDCl3) δ 12.66 (s, 1H), 10.03 (s, 1H),
9.44 – 9.39 (m, 1H), 8.36 (d, J = 8.5 Hz, 1H), 8.09 (s, 1H), 7.95 – 7.90 (m, 1H), 7.83 – 7.75
(m, 3H), 7.72 (dd, J = 7.7, 1.6 Hz, 1H), 7.59 (d, J = 8.9 Hz, 1H), 7.55 – 7.49 (m, 1H), 7.45
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(t, J = 7.9 Hz, 1H), 7.24 (dt, J = 6.7, 3.8 Hz, 6H), 5.19 (d, J = 13.8 Hz, 1H), 5.07 (d, J =
13.8 Hz, 1H), 4.25 – 4.15 (m, 1H), 4.11 – 4.03 (m, 1H), 1.27 (t, J = 7.2 Hz, 3H).
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1.4.4 Irradiation of Photoprecursors
Photochemical [4+2] Diels Alder reaction (General procedure F)
Photoprecursor (0.5 mmol) was dissolved in Methanol (50 mL), and the solution was
degassed by bubbling nitrogen for 1 h. The mixture was irradiated with UV LED-based
illuminator, seven 2.9 W @ 365 nm LED Engin chips (or two for 1f) with reaction progress
monitored by 1H NMR. Photoprecursors converted 100 % to photoproduct and was
modified in one step.
Photoprecursor

Photoproduct

LED Power

Reaction

(W)

time (h)

1.1b

20

3

1.2b

20

12

1.3b

20

7

1.4b

20

1

56

1.5b

20

1

20

2

20

12

1.8b

20

3

1.9b

20

8

1.10b

20

3

1.6b

1.7b

57

1.11b

20

7

1.12b

20

4

1.13b

20

10

1.14b

20

2

15b

20

6

16b

20

1

17b

20

3

58

1.4.5 Postphotochemical modifications

benzofuro[3,2-b]quinolone (1.1c): General procedure G was followed on a (0.25 g, 0.53
mmol) scale of photoproduct 1.1b in 50 mL of methanol. The reaction was left at 75°C for
3 hrs, after work up and purification by flash chromatography on silica gel (gradient
elution: hexane → hexane–ethyl acetate 4:1); which after two steps afforded 76 mg (61 %)
of the title compound 1H NMR (500 MHz, Chloroform-d) δ 8.43 (ddd, J = 7.7, 1.3, 0.7 Hz,
1H), 8.34 (ddt, J = 8.6, 1.4, 0.8 Hz, 1H), 8.22 – 8.17 (m, 1H), 8.03 – 7.97 (m, 1H), 7.77
(ddd, J = 8.5, 6.8, 1.5 Hz, 1H), 7.72 – 7.59 (m, 3H), 7.51 (ddd, J = 7.7, 6.9, 1.3 Hz, 1H).13C
NMR (126 MHz, CDCl3) δ 159.6, 147.9, 147.5, 146.1, 130.9, 129.3, 128.0, 127.9, 127.4,
126.1, 123.6, 122.9, 122.3, 114.5, 112.2, 77.3, 77.0, 76.8.

benzofuro[3,2-b][1,8]naphthyridine (1.2c): General procedure G was followed on a
(0.21 g, 0.45 mmol) scale of photoproduct 1.2b in 50 mL of methanol. The reaction was
left at 75°C for 3 hrs after work up and purification by flash chromatography on silica gel
(gradient elution: hexane → hexane–ethyl acetate 4:1); which after two steps afforded 83
mg (84 %) of the title compound as a white solid. 1H NMR (500 MHz, Chloroform-d) δ
9.16 (dd, J = 4.2, 2.0 Hz, 1H), 8.48 (d, J = 7.7 Hz, 1H), 8.37 – 8.28 (m, 1H), 8.17 (s, 1H),
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7.70 (t, J = 7.8 Hz, 1H), 7.63 (d, J = 8.3 Hz, 1H), 7.52 (dt, J = 15.8, 7.8 Hz, 2H). 13C NMR
(126 MHz, CDCl3) δ 160.12, 153.64, 152.10, 150.24, 147.86, 137.19, 131.78, 124.00,
123.20, 122.67, 121.71, 121.31, 115.09, 112.23. HRMS (ESI) calcd for C14H9N2O +
(MH+) 221.0715, found 221.0710.

17‐oxa‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.3c): General procedure G was followed on a (0.06 g, 0.12 mmol) scale of photoproduct
1.3b in 50 mL of methanol. The reaction was left at 75°C for 12 hrs after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 4:1); which after two steps afforded 13 mg (49 %) of the title compound as a
white solid1H NMR (500 MHz, Chloroform-d) δ 9.06 (dd, J = 4.2, 1.7 Hz, 1H), 8.77 – 8.62
(m, 1H), 8.51 (s, 1H), 8.47 – 8.38 (m, 1H), 7.76 – 7.71 (m, 2H), 7.71 – 7.68 (m, 1H), 7.54
(ddd, J = 7.9, 7.1, 1.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 160.2, 150.2, 150.1, 148.4,
142.7, 141.4, 137.5, 131.7, 124.1, 122.9, 122.4, 122.2, 115.7, 112.5. HRMS (ESI) calcd
for C14H9N20 + (MH+) 221.0715, found 221.0712

benzo[b]benzofuro[2,3-g][1,8]naphthyridine (1.4c): General procedure G was followed
on a (0.076 g, 0.15 mmol) scale of photoproduct 1.4b in 50 mL of methanol. The reaction
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was left at 75°C for 48 hrs after work up and purification by flash chromatography on silica
gel (gradient elution: hexane → hexane–ethyl acetate 1:4); which after two steps afforded
18 mg (44 %) of the title compound as a yellow solid. 1H NMR (500 MHz, Chloroform-d)
δ 9.03 (s, 1H), 8.53 (d, J = 7.8 Hz, 1H), 8.31 (s, 1H), 8.08 (d, J = 8.4 Hz, 1H), 7.89 (t, J =
7.7 Hz, 1H), 7.76 (td, J = 7.7, 7.1, 1.3 Hz, 1H), 7.63 (dd, J = 8.2, 4.9 Hz, 2H), 7.53 (t, J =
7.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 161.2, 154.2, 151.7, 148.6, 147.5, 138.7, 133.2,
131.5, 128.9, 127.5, 126.6, 126.3, 124.2, 124.0, 122.4, 120.2, 114.1, 112.3, 77.3, 77.0, 76.8.
HRMS (ESI) calcd for C18H10N2O + (MH+) 271.0871, found 271.0877

benzofuro[2,3-g]naphtho[1,2-b][1,8]naphthyridine (1.5c): General procedure G was
followed on a (0.12 g, 0.21 mmol) scale of photoproduct 1.5b in 50 mL of methanol. The
reaction was left at 75°C for 48 hrs after work up and purification by flash chromatography
on silica gel (gradient elution: hexane → hexane–ethyl acetate 1:4); which after two steps
afforded 68 mg (86 %) of the title compound as a yellow solid. 1H NMR (500 MHz,
Chloroform-d) δ 9.78 (dd, J = 7.9, 1.5 Hz, 1H), 8.85 (s, 1H), 8.63 (dt, J = 7.7, 1.0 Hz, 1H),
8.36 (s, 1H), 7.93 (dd, J = 7.8, 1.4 Hz, 1H), 7.88 – 7.79 (m, 4H), 7.76 (ddd, J = 8.5, 7.2,
1.4 Hz, 1H), 7.68 (d, J = 8.2 Hz, 1H), 7.61 – 7.51 (m, 1H). 13C NMR (126 MHz, CDCl3) δ
160.6, 152.1, 152.1, 149.2, 147.6, 136.3, 134.0, 132.3, 131.3, 129.6, 128.6, 127.9, 127.5,
126.2, 125.3, 124.9, 124.0, 123.6, 122.8, 120.6, 114.4, 112.3. HRMS (ESI) calcd for
C22H12N2O + (MH+) 321.0327, found 321.1021
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benzofuro[2,3-e]thieno[3,2-b]pyridine (1.6c): General procedure G was followed on a
(0.097 g, 0.21 mmol) scale of photoproduct 1.6b in 50 mL of methanol. The reaction was
left at 75°C for 48 hrs after work up and purification by flash chromatography on silica gel
(gradient elution: hexane → hexane–ethyl acetate 1:4); which after two steps afforded 28
mg (59 %) of the title compound as a yellow solid. 1H NMR (500 MHz, Chloroform-d) δ
8.37 – 8.33 (m, 1H), 8.33 (d, J = 0.8 Hz, 1H), 7.79 (d, J = 5.6 Hz, 1H), 7.73 (dd, J = 5.6,
0.8 Hz, 1H), 7.67 – 7.60 (m, 2H), 7.49 (ddd, J = 8.0, 6.4, 1.8 Hz, 1H). 13C NMR (126 MHz,
CDCl3) δ 158.4, 153.0, 147.4, 143.9, 131.8, 129.7, 129.6, 124.6, 123.6, 123.1, 121.4, 112.3,
112.2. HRMS (ESI) calcd for C13H7NOS + (MH+) 226.0327, found 226.0323.

benzo[4,5]thieno[3,2-b]benzofuro[2,3-e]pyridine (1.7c): General procedure G was
followed on a (0.081 g, 0.16 mmol) scale of photoproduct 1.7b in 50 mL of methanol. The
reaction was left at 75 oC for 7 days, after work up and purification by flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 5:1); which
after two steps afforded 0.16 mg (37 %) of the title compound as a bright yellow solid. 1H
NMR (500 MHz, Chloroform-d). 1H NMR (500 MHz, CDCl3) δ 8.72 – 8.66 (m, 1H), 8.42
(d, J = 7.7 Hz, 1H), 8.30 (s, 1H), 7.94 – 7.88 (m, 1H), 7.66 (t, J = 8.1 Hz, 2H), 7.61 (td, J
= 6.8, 5.7, 4.0 Hz, 3H), 7.52 (t, J = 7.3 Hz, 1H).
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17‐oxa‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.8c): General procedure G was followed on a (0.09 g, 0.19 mmol) scale of photoproduct
1.8b in 50 mL of methanol. The reaction was left at 75°C for 8 hrs, after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 4:1); which after two steps afforded 26 mg (62 %) of the title compound as a
white solid. 1H NMR (500 MHz, Chloroform-d) δ 8.75 (dd, J = 7.6, 1.8 Hz, 1H), 8.66 (dd,
J = 4.9, 1.8 Hz, 1H), 8.33 (dd, J = 8.5, 1.0 Hz, 1H), 8.30 (s, 1H), 8.03 (dd, J = 8.2, 1.4 Hz,
1H), 7.80 (ddd, J = 8.5, 6.8, 1.5 Hz, 1H), 7.67 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.52 (dd, J =
7.6, 4.9 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 165.8, 149.9, 146.6, 146.3, 145.3, 131.7,
129.3, 128.5, 128.1, 127.8, 126.8, 120.1, 115.9, 115.4. . HRMS (ESI) calcd for C14H9N2O
+ (MH+) 221.0715, found 221.0709.

17‐oxa‐7,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐
octaene (1.9c): General procedure G was followed on a (0.16 g, 0.35 mmol) scale of
photoproduct 1.9b in 50 mL of methanol. The reaction was left at 75°C for 8 hrs, after
work up and purification by flash chromatography on silica gel (gradient elution: hexane
→ hexane–ethyl acetate 4:1); which after two steps afforded 34 mg (44 %) of the title
compound as a white solid. 1H NMR (500 MHz, Chloroform-d) δ 9.22 (dd, J = 4.1, 1.9 Hz,
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1H), 8.81 (dd, J = 7.6, 1.8 Hz, 1H), 8.69 (dd, J = 4.9, 1.8 Hz, 1H), 8.41 (dd, J = 8.2, 2.0
Hz, 1H), 8.32 (s, 1H), 7.61 (dd, J = 8.2, 4.1 Hz, 1H), 7.55 (dd, J = 7.6, 4.9 Hz, 1H). 13C
NMR (126 MHz, CDCl3) δ 166.2, 153.7, 152.7, 150.8, 148.1, 146.6, 137.4, 132.8, 122.4,
121.9, 120.6, 116.2, 115.7. HRMS (ESI) calcd for C13H8N3O + (MH+) 222.0667, found
222.0669.

17‐thia‐9‐azatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.10c): General procedure G was followed on a (0.10 g, 0.21 mmol) scale of photoproduct
1.10b in 50 mL of methanol. The reaction was left at 75°C for 48 hrs after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 4:1); which after two steps afforded 43 mg (88 %) of the title compound as a
yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 8.70 (ddd, J = 7.7, 1.5, 0.7 Hz, 1H),
8.63 (s, 1H), 8.35 – 8.31 (m, 1H), 7.98 – 7.93 (m, 1H), 7.89 (dt, J = 7.9, 0.9 Hz, 1H), 7.80
(ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.68 – 7.63 (m, 1H), 7.63 – 7.58 (m, 2H). 13C NMR (126
MHz, CDCl3) δ 154.5, 150.9, 141.8, 141.8, 141.6, 137.3, 135.2, 133.5, 130.4, 130.3, 125.4,
124.2, 123.7, 123.2. HRMS (ESI) calcd for C15H10NS + (MH+) 236.0534, found 236.0527
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17‐thia‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.11c): General procedure G was followed on a (0.09 g, 0.20 mmol) scale of photoproduct
1.11b in 50 mL of methanol. The reaction was left at 75°C for 2 days, after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 1:4); which after two steps afforded 25 mg (53 %) of the title compound as a
yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 9.05 (d, J = 3.9 Hz, 1H), 8.85 (s, 1H),
8.67 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 7.9 Hz, 1H), 7.75 – 7.65 (m,
2H), 7.61 (t, J = 7.6 Hz, 1H).13C NMR (126 MHz, CDCl3) δ 163.6, 151.4, 151.2, 146.7,
131.4, 130.6, 129.6, 129.4, 129.3, 128.5, 127.2, 127.0, 126.7, 120.2. HRMS (ESI) calcd
for C14H9N2S + (MH+) 237.0486, found 237.0489

17‐thia‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.12c): General procedure G was followed on a (0.10 g, 0.20 mmol) scale of photoproduct
1.12b in 50 mL of methanol. The reaction was left at 75°C for 3 days, after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 4:1); which after two steps afforded 37 mg (78 %) of the title compound as a
yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 8.88 (dd, J = 7.9, 1.7 Hz, 1H), 8.81
(dd, J = 4.7, 1.7 Hz, 1H), 8.66 (s, 1H), 8.31 (d, J = 8.6 Hz, 1H), 7.99 – 7.93 (m, 1H), 7.82
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(ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.65 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.54 (dd, J = 7.8, 4.7
Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 163.6, 151.4, 151.2, 146.7, 131.4, 130.6, 129.6,
129.4, 129.3, 128.5, 127.2, 127.0, 126.7, 120.2. HRMS (ESI) calcd for C14H9N2S + (MH+)
237.0486, found 237.0487

17‐thia‐4,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐
octaene (1.13c): General procedure G was followed on a (0.073 g, 0.15 mmol) scale of
photoproduct 1.13b in 50 mL of methanol. The reaction was left at 75°C for 3 days, after
work up and purification by flash chromatography on silica gel (gradient elution: hexane
→ hexane–ethyl acetate 1:4); which after two steps afforded 0.21 mg (59 %) of the title
compound as a yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 9.10 (dd, J = 4.1, 1.7
Hz, 1H), 8.93 (s, 1H), 8.88 (dd, J = 7.8, 1.7 Hz, 1H), 8.85 (dd, J = 4.7, 1.8 Hz, 1H), 8.62
(d, J = 8.2 Hz, 1H), 7.76 (dd, J = 8.6, 4.1 Hz, 1H), 7.58 (dd, J = 7.8, 4.7 Hz, 1H). 13C NMR
(126 MHz, CDCl3) δ 163.9, 152.1, 151.7, 151.4, 142.2, 142.0, 137.3, 134.2, 131.7, 130.9,
127.9, 124.0, 120.5. HRMS (ESI) calcd for C13H12N3S + (MH+) 238.0439, found 238.0437

17‐thia‐9,14‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.14c): General procedure G was followed on a (0.11 g, 0.23 mmol) scale of photoproduct
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1.14b in 50 mL of methanol. The reaction was left at 75 oC for 4 days, after work up and
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 5:1); which after two steps afforded 36 mg (66 %) of the title compound as a
bright yellow solid. 1H NMR (500 MHz, Methanol-d4) δ 9.49 (s, 1H), 9.14 (s, 1H), 8.86
(q, J = 5.7 Hz, 2H), 8.35 (dd, J = 8.7, 1.0 Hz, 1H), 8.24 – 8.09 (m, 1H), 8.07 – 7.89 (m,
1H), 7.81 (ddd, J = 8.1, 6.7, 1.2 Hz, 1H). 13C NMR (126 MHz, MeOD) δ 157.2, 150.1,
146.8, 143.5, 142.3, 140.6, 138.7, 133.2, 131.3, 130.3, 128.8, 128.0, 127.4, 118.4. HRMS
(ESI) calcd for C14H8N2S + (MH+) 237.0486, found 237.0484

quinolino[3',2':4,5]thieno[3,2-b][1,8]naphthyridine (1.16c): General procedure G was
followed on a (0.11 g, 0.20 mmol) scale of photoproduct 1.15b in 50 mL of methanol. The
reaction was left at 75 oC for 4 days, after work up and purification by flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 5:1); which
after two steps afforded 23 mg (39 %) of the title compound as a bright yellow solid. 1H
NMR (500 MHz, Chloroform-d). 1H NMR (500 MHz, CDCl3) δ 9.2 (s, 1H), 9.2 (dd, J =
7.2, 1.6 Hz, 1H), 8.2 (d, J = 8.4 Hz, 1H), 8.2 (d, J = 8.7 Hz, 1H), 8.1 (dd, J = 6.9, 1.6 Hz,
1H), 7.9 (ddd, J = 8.5, 6.8, 1.5 Hz, 1H), 7.7 (ddd, J = 7.9, 6.7, 1.1 Hz, 1H), 7.3 (t, J = 7.2
Hz, 1H), 6.5 (s, 1H).
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thieno[3,2-b:5,4-f']diquinoline (1.17c): General procedure G was followed on a (0.08 g,
0.15 mmol) scale of photoproduct 13b in 50 mL of methanol. The reaction was left at 75
o

C for 7 days, after work up and purification by flash chromatography on silica gel (gradient

elution: hexane → hexane–ethyl acetate 5:1); which after two steps afforded 21 mg (49 %)
of the title compound as a bright yellow solid. 1H NMR (500 MHz, MeOD) δ 10.95 –
10.87 (m, 1H), 9.00 (dd, J = 4.4, 1.7 Hz, 1H), 8.98 (s, 1H), 8.39 (d, J = 8.6 Hz, 1H), 8.32
(d, J = 9.0 Hz, 1H), 8.24 (d, J = 8.9 Hz, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.92 – 7.84 (m, 2H),
7.78 – 7.67 (m, 1H).
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Chapter Two
Photoassisted Synthesis of cryptolepine and its Derivatives
2.1 Introduction of Indoloquinolines
2.1.1 Biological Studies
In previous literature, there have been studies that cryptolepine and other alkyl
substituted indoloquinolines display biological activity; as well as benzothienoquinoline
scaffolds. They have revealed that these can be used to treat bacterial infections,
inflammation, and pain.10 In the past decades, more attention has been shifted to antiinfective agents since increasing bacterial infections in humans are caused by opportunistic
pathogens.

These

opportunistic

pathogens

cause

infectious

diseases

in

immunocompromised patients, causing an onset of genetic defects or immunosuppressive
activity; such as malaria, HIV, and measles.11 Moreover, anti-infective agents are
continuously studied as a result of resistance in current therapies.
Due to the biological activity of indoloquinolines, early stages of research methods
were developed with the use of applicable starting materials; however, at the expense of a
multistep synthesis. Cryptolepine and various cryotelois species are extracted and used in
traditional medicine.
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In 1906, Fichter and Boehringer were the first to synthesize indolo[3,2-b]quinoline
undergoing a multistep synthesis, which was done before it had been isolated by a natural
source.12 After this synthesis, this natural product was targeted due to its biological activity
and ability to treat tropical diseases, such as malaria. Early studies on the synthesis of
cryptolepine were inefficient, but over the century, the proficiency has increased. However,
the current method of choice is still extraction.13 Dry powder roots of C. sanguinolenta are
percolated in acetic acid with water for 48 hours. This solution is filtered and extracted
with chloroform which is later purified by a chromatotron. The yield of cryptolepine is
0.13 % at a 1.12 kg scale. Though this is the method of choice, there must be a more
efficient synthetic route to target the natural product cryptolepine.
2.1.2 Synthesis of Indoloquinolines
In 1996, Joule et al. demonstrated that set v, in Figure 2.1, does a nucleophilic
substitution at an indole (β – position) where the indole carries a phenylsulfonyl group on
nitrogen and a ketonic substituent at C-2; the N-substituent is eliminated as phenylsulfinate.
Previously, they reported using a hydroxyl group as a nucleophile which was changed to
an amide nitrogen in order to access the synthesis of hydroxycryptolepine, cryptolepine
and quindoline.14
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Figure 2.1

Timari et al. showed that Suzuki cross coupling of pivaloylamino phenylboronic
acid 2.7 with 2-quinolyl trifluoromethanesulfonate 2.6 affords biaryl compound 2.8.15 The
quinoline nitrogen was introduced with m-CPBA, which allowed for blockage of ring
closure with N-oxide. After hydrolysis, the amino-substitute was transformed to the azide
derivative via diazotation followed by a reaction with sodium azide. Previous synthetic
routes showed under thermos conditions cyclization of azide produces polyfused
heterocycles, which in this case, produced quinoline 2.11 in moderate yields, Figure 2.2.
Unfortunately, this synthetic route did not access indoloquinolines, but tetracvclic
indazoloquinoline.

Figure 2.2: Synthetic route to tetracyclic indazoloquinoline
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Looking at the synthetic route, a promising approach would be to use a diaryl
quinoline as the starting material to ultimately give ring closure, instead of using azide
nitrene ring closure, Figure 2.3. This is a simple 3 step procedure giving indoloquinoline
in moderate yields; however, the starting materials are rather expensive in return for small
recovery of indoloquinoline.

Figure 2.3: Diaryl approach to quindoline

Mendez et al. used the same methods as Timari et al. for the cyclization, relying on
Buchwald-Hartwig conditions, Figure 2.4.16 Looking at the retro synthesis of 2arylquinoline, the appropriate precursors are 2-aminobenzaldehyde and acetophenone.
However, 2-aminobenzaldehyde 2.15 is not stable and highly unstable, but it is accessible
from 2-nitrobenzaldehyde 2.2 through a reduction reaction. This aminoaldehyde 2.15 was
condensed with acetophenone 2.16 under Friedlander conditions followed by copper
acetate and AgNO3 to afford the 2-arylquinoline in low yields. 2-arylquinoline undergoes
a transformation to synthesize the indoloquinoline in optimized palladium Buchwald72

Hartwig conditions with moderate yields. This paper shows inefficiency in their procedures
and is similar to previous research, the difference is the cyclization conditions, but the
schematics are analogous.

Figure 2.4: Buchwald-Hartwig conditions for cyclization to quindoline

Zhou et al. was able to make indoloquinoline in one pot, but with scarce starting
materials. The synthesis of indoloquinoline derivatives were produced by a Brønsted
acid/Mn (III) via a dihydroxylation, azidation, and cyclization casacade of diarylmethanols
with trimethylsilyl azide as seen in Figure 2.5.17

Figure 2.5

73

The proposed mechanism is that the starting material 2.20 was dihydroxylated by
the presence of p-toluene sulfonic acid monohydrate. Afterwards, the intermediate is
converted to a carbocation, and then rearranged. The rearranged carbocation is then reacted
with an azide anion, which is then oxidized by Mn(III) to form a radical cation. After
deprotonation of the radical cation, denitrogenative fragmentation afforded an iminyl
radical that underwent a radical cyclization into a spiro intermediate, which does a ring
expansion into two free radicals. This was converted to the final product 2.21 and 2.21’ in
good yields, Figure 2.6. This method offers an economical catalytic system by forming two
C(sp2)-N bonds, two C(sp2)-H, and ring formation; furthermore, cleaving an C(sp3)−O
bond. However, there are limitations in the starting materials because they are expensive
and hard to attain. Unfortunately, indoloquinoline cannot be synthesized because of the
limitations with the aryl groups, only making derivatives. Moreover, this reaction did not
work with benzofuran and single aryl in the starting materials, showing the restrictions.
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Figure 2.6: Plausible mechanism of the conversion
reaction of 2-diarylindolylmethanols

Shuvalov et al. previously obtained δ-carbolines in a two-step process, in low to
moderate yields.18 2-aryl-3-nitro-5-iodopyridines 2.32 were used to synthesize δcarbolines

by

reductive

bis(diphenylphosphino)ethane

Cadogan
(DPPE).

cyclization
These

in

the

presence

of

1,2-

2-aryl-3-nitro-5-iodopyridines

were

synthesized by 5-acetyl-3-nitropyridine in two steps: first by using the Schmidt reaction,
the acetyl group is substituted with an amino group, and second, the diazo group was
replaced with iodine.
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Figure 2.7: Synthesis of δ-carbolines

They also used this method to synthesize indoloquinolines using reductive
cyclizing

tertrahydroquinolines

2.36

followed

by

aromatization.

These

tetrahydroquinolines were produced by merging nitroacetophenone enamines 2.35 and 2hydroxymethylenecyclohexanone 2.34. Aromatization is carried out using Pd/C while
heating with diphenyl ether, Figure 2.8.

Figure 2.8: Reductive cyclizing tetrahydroquinolines and
aromatization to synthesize quindolines

Overall, many labs are studying indoloquinolines and their derivatives for their
biological activity; but still, there is no real general procedure to synthesize these with one
systematic scheme. Additionally, with many synthetic labs targeting these aromatic flat
compounds, there are still disadvantages to their methods as seen in Figure 2.9. Our
approach is economical, universal, and high yielding.
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Figure 2.9: Summary of methods used for the synthesis of quindoline

2.2 Synthesis of cryptolepine and its Derivatives
2.2.1 Background on Photoassisted Diversity-Oriented Synthesis
In this work, we were able to strategically design a photoprecursor framework,
which undergoes [4+2] Diels-Alder cycloaddition through ESIPT upon irradiation. These
photoproducts are introduced to post-photochemical modifications, which allows these
compounds to reach full aromatization.
To target these intricate photoproducts, we must understand the excited state of the
photoprecursor to control and tailor the design of these complexes. In this lab, there have
been access to complex polyheterocyclic architectures through a triplet aza-o-xylene
intermediate which were met with an oxalyl anilide tether. Previously, we were able to
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design photoprecursors with a photoactive core and unsaturated pendant, which was linked
with oxalyl chloride. Due to very few limitations of the photochemical step, we
successfully isolated many aromatic flat polyheterocycles with high yields.
2.2.2 Synthetic Design of Photoprecursor
Cryptolepine is examined immensely for its variety of treatments and it has been
found that they intercalate into DNA; specifically, DNA with numerous GC base pairs.
Furthermore, after multiple in vitro and in vivo studies, it has been recognized that
cryptolepine with methyl substituent at N-5 shows a higher biological activity than a
methyl substituent at N-10. Methylation at the N-5 is important for biological activity, but
not necessary. Cryptolepine hydrochloride salt (methyl at N-10) showed the equivalent
biological activity as the cryptolepine (methyl at N-5).12 Biological activity is not limited
to indoloquinolines; benzothienoquinoline salts have shown to have biological activity
aswell.11
In this research, we targeted cryptolepine due to its biological activity and its
importance in the scientific community. First, we must look at the retrosynthetic route on
targeting the natural product, which allows for an optimal photoprecursor, Figure 2.10.
This synthetic route it designed by my results in Project 1.
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Figure 2.10: Retrosynthetic route to cryptolepine

Here, we looked at different kinds of modified products that are derivatives of our
final modified products in Project 1. The 10H-indolo[3,2-b]quinoline 2.5 would be
synthesized from the protected indolo-quinoline 2.51 thru deprotection of the indolenitrogen. The modified photoproduct 2.51 should be easily accessible from the
photoprecursor 2.52 by irradiation and modification in a one pot synthesis. The
photoproduct 2.53 is designed with a substrate and a photoactive core that are tethered
together by a scaffold, which is later removed in the basic catalyzed modification process.
The time constraint part of this synthesis was the modification of the photoproduct.
During this modification step under strong basic conditions such as sodium methoxide and
potassium tert-butoxide, the photoproduct would break open and return to the
photoprecursor. Therefore, the protecting group on the indole was significant in isolating
the modified product 2.51.
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2.2.2.1 Ester Protected Indole
During substrate design, there were many approaches to reduce costs. Fortunately,
Jarjani et al. was able to synthesize 3-amino-1H-2-carboxylates in four steps in moderate
yields.19 2-aminobenzonitrile 2.54 and its derivatives adds to the possibility of synthesizing
a variety of 3-amino-1H-2-carboxylates. Even though there have been studies without
protecting the amino group, the protection free method does not appear to be generalizable;
therefore, they approached the synthesis of 3-amino-1H-2-carboxylates by protecting the
amino group which are later removed with Pd-C.

After the protection of

aminobenzonitrile, the were converted into corresponding glycinate.

Figure 2.11: Synthesis of carbamate ester

In Figure 2.11, after the protection of aminobenzonitrile with an ester, compound
2.55 was converted into the corresponding glycinate esters using sodium hydride and
bromoacetate esters. Next, the sodium hydride efficiently promoted the addition of the
glycinate α-carbon to the cyano group at low temperatures (-40 oC). This results in the
formation of an indole protected core with the 3 -amino and 2-carboxylate groups. With
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the ethoxy-ester as the protecting group, the deprotection failed; therefore, this substrate
was moved onto the synthesis of the photoprecursor, which we are hoping will later be
deprotected.

Figure 2.12: Benzylation via reductive elimination

1-ethyl 2-methyl 3-amino-1H-indole-1,2-dicarboxylate 2.57 was protected by
benzyl through reductive amination allowing for the synthesis of substrate 2.58, Figure
2.12.

Figure 2.13: Synthesis of ester protected indole photoprecursor

1-ethyl 2-methyl 3-(benzylamino)-1H-indole-1,2-dicarboxylate 2.58 was reacted
with excess oxalyl chloride in dichloromethane. After completion, this round bottom flask
was put under reduced pressure to remove the excess oxalyl chloride and dichloromethane,
then this intermediate was dissolved in the dichloromethane and added dropwise to the
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acetal protected aminobenzaldehyde with N,N-diisopropylethylamine. After the reaction
went to completion, compound 2.60 was deprotected with toluene-sulfonic acid in acetone
to give the final photoprecursor 2.61, Figure 2.13.

Figure 2.14: irradiation of ester protected photoprecrusor
followed by base-catalyzed aromatization

Next, this photoprecursor 2.61 was irradiated in methanol at 365 nm under nitrogen
atmosphere to give photoproduct 2.62 in moderate yields, Scheme 2.10. This was then
modified in methanol under basic conditions to give ethyl 10H-indolo[3,2-b]quinoline-10carboxylate. Unfortunately, after the modification, we unsuccessfully deprotected the
ethoxy-ester on the indole. This allowed us to investigate different protecting groups.
2.2.2.2 Cbz Protected Indole
The aminobenzonitrile was protected with benzyl chloroformate leading to a cbz
protected indole that was later used for the synthesis of the photoprecursor. After
irradiation and modification of photoprecursor 2.67, the protected indoloquinoline was
isolated in moderate yields.
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Figure 2.15: Synthesis of carbamate ester with Cbz-protected indole

Unfortunately, we were unable to isolate 10H-indolo[3,2-b]quinoline because the
deprotection of cbz was not permitted. Even with a different strategy of deprotecting before
modification and irradiation, product 2.50 was not obtained.

Figure 2.16: cbz-deprotection no permitted after
irradiation and modification

2.2.2.3 Benzyl-protected Indole
Previous research on the synthesis of cryptolepine showed a benzyl deprotection,
which led to the followed finalized Figure 2.17 in the synthesis of the substrate.20
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Figure 2.17: Benzyl protected indole for photoprecursor design

The benzyl ester in compound 2.66 is easily deprotected with Pd – C under
hydrogen atmosphere. The free amine and indole are then protected with benzyl bromide,
giving the di-benzylation product 2.68. In this reaction, there is a minor bis-benzylated
product but with a refined and regulated procedure this minor product could be further
minimized.
Continuing the study with this substrate, we were able to successfully isolate
photoprecursor 2.70 in good yields, Figure 2.18.

Figure 2.18: 2-step synthesis of benzyl protected photoprecursor

After photoprecursor 2.70 was isolated, it was irradiated in methanol at 365 nm to
yield photoproduct 2.71, which underwent a 4+2 Diels - Alder cycloaddition initiated by
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ESIPT that generated a triplet axa-o-xylylene, Figure 2.19. The photochemical reaction
produced only one product; however, due to the long irradiation time some product
decomposed affecting the photoproduct yield.

Figure 2.19: ESIPT generated aza-o-xylylene
of indole unsaturated pendant

2.2.3 Photoassisted Synthesis to cryptolepine

This photoproduct was modified with potassium carbonate under reflux to form
product 2.72. After modification, 10-benzyl-10H-indolo[3,2-b]quinoline was deprotected
with potassium tert-butoxide in DMSO, which changed the reaction color from yellow to
bright pink, confirming reaction completion. Methylation of the pure 10H-indolo[3,2b]quinoline 2.5 gave the natural product Cryptopline , Figure, 2.20.21
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Figure 2.20: Photoassisted Synthesis of cryptolepine

2.3 Methylation of Aromatic Polyheterocycles
2.3.1 Effect of Methylation on Biological Activity
Ablordeppey et al. investigated the structure activity relationships associated with
various alkyl groups at the 5 and 10 positions of the quindoline moiety. To target the N-5
position of the indoloquinoline, the conditions were iodomethane in sulfolane at 50 oC. To
target the N-10 positions the conditions are iodomethane in potassium hydroxide in acetone
at room temperature.21
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We continued with the studies and applied them to different aminobenzonitriles to
determine the complexity of this scheme, hoping that we can synthesis a biological active
compound. When synthesizing the methyl 3-amino-1H-indole-2-carboxylate substrate, we
started with the reagent 2-aminonicotinonitrile to add a pyridine heterocycle instead of a
simple benzene to the indole. Following the general procedure for each step, we were able
to isolate a derivative to the natural product cryptolepine. We continued with the scope,
allowing us to synthesize additional examples.

Biological studies were done on many forms of indoloquinolines, and it was studied
that methylation on the N-5 gives biological activity to indoquinoline. Cryptolepine
possess renal vasodilation and inhibition of platelet aggregation properties that are
associated with the presence of alkylation at the N-5 of cryptolepine. 22 Also, Bierer et al.
discovered antihyperglycemic properties of cryptolepine through in vitro and in vivo
studies.23 For their studies, they were able to isolate cryptolepine in very little amounts;
moreover, their planned biological evaluation of the natural product required multigram
quantities. Therefore, the synthetic approach was the only alternative. Bierer et al. synthetic
procedure required a bomb but gave descent yields after 4 to 7 steps. Methyl triflate was
their source of alkylation on the indoloquinoline, affording the highest yields.
In the Bierer et al. invitro studies, cryptolepine and its salt forms were tested for
their ability to stimulate glucose transport in 3T3-L1 adipocytes. A concentration of 3 µM
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of cryptolepine showed an increased ability to stimulate glucose transportation; activity
increased with increasing concentration. Furthermore, the regioisomer of cryptolepine,
methylation at N-10, was inactive in the invitro studies, indicating the importance of the
methyl group at the N-5 position. The in vivo studies showed cryptolepine lowered mean
plasma glucose levels in db/bd mice 20 % from the pre-dose levels 3 hours post-dose and
30 % 24 hours post-dose at 100 mg/kg, Table 2. The hydrochloride salt lowered the mean
plasma glucose levels 3 hours post-dose by 43.1 % compared to hydroiodide salt at 22.5
%. Also, in this model the regioisomer with methylation at N-10 was inactive.

vehicle

treatment

plasma glucose
(% change of
pre-dose)
___________
3h
24 h

mean body weight
(g/mouse)
________________
0h
24 h

food intake
(g/mouse/day)
__________
48 h

-3.6

8.6

41.3 ± 0.6

41.5 ± 0.8

4.0

2.50

100 mg/kg

-19.7

-30.0

39.4 ± 1.5

38.7 ± 1.4

1.0

2.77

100 mg/kg

-16.4

-43.1

41.0 ± 0.5

39.8 ± 0.5

0.9

2.73

100 mg/kg

-11.5

-22.5

42.7 ± 1.3

41.9 ± 1.6

1.0

2.74

100 mg/kg

15.3

14.1

41.4 ± 1.3

42.0 ± 1.5

4.4

Table 2
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2.3.2 Methylation of Aromatic Polyheterocycles
Knowing the methylation on the N-5 of cryptolepine is important to the biological
activity of the natural product, caused the investigation of methylation to other fully
aromatic heterocycles. Using the final products of benzofuro[3,2-b]quinolone 2.78, 17‐
thia‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene 2.79,
and

17‐thia‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐

octaene 2.80, we methylated the compounds to see if the methylation affected the
biological activity of the compounds, Figure 2.21.

Figure 2.21: Scope of methylated aromatic pyridines

Bierer et al. was able to determine that the triflate counter ion affected the biological
activity. The hydrochloride salt showed increase activity than the hydroiodide salt;
therefore, additional studies on the counter ions of compounds 2.78-2.80 should be further
investigated.
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Compound 2.80 is methylated at the N-15 and not at the N-9 position. Looking at
the 2D NMR spectra, the proposed structure is correct, Figure 2.22-2.25.

Figure 2.22: HSQC in Methanol-d4

In the HSQC, there is a signal with the singlet at roughly 4.7 ppm that integrates to
three, which are the protons on C-17. Looking at peak 160 ppm on the carbon side of the
2D spectra, the C-16 has no signal with a proton, which indicated C-16 as a tertiary carbon
in the structure. Now looking at the HMBC (Figure 2.24), we can assume that the
methylation occurs at N-15.
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Figure 2.23: Zoomed in HSQC

91

Figure 2.24: HMBC in Methanol-d4

Figure 2.25: HMBC in Methanol-d4 zoomed in
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Analyzing the HMBC, there is a clear signal of the proton on the methyl group with
two other carbons; recall HMBC allows us to see signals that are 2 to 3 bonds way from a
proton and a carbon. Looking back at the HSQC (Figure 2.22 and 2.23), one out of the two
carbons that has a signal with the methyl proton is a C-H carbon. Therefore, we can accept
that the methylation occurs at N-15 due to the HMBC spectra showing a C-14 carbon signal
with the H-17. If the methylation occurs at the N-9, there should not be a signal of the
proton on the methyl group with a C-H carbon because C-8 and C-10 are tertiary carbons.
Looking at the full HMBC, we can support the idea of the methylation occurring at N-15.
The protons from the methyl has a signal with C-14 and C-16; furthermore, the H-14 has a
signal with C-16.
Compounds 2.78-2.80 were synthesized with moderate to good yields and were
submitted to the National Cancer Institute. Unfortunately, they show no biological activity
with the cell lines they were tested with; however, from past studies it was shown that the
triflate counter ion affected the biological activity. In future studies, the counter ion can be
exchanged with chloride or iodide by an ion exchange resin.

2.4 Synthesis of the Natural Product justbetonin
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After targeting the natural product cryptolepine, our lab came across a second
natural product with the quindoline core, jusbetonin, the first natural indolo[3,2b]quinoline alkaloid glycoside isolated from the leaf extract of Justicia betonica. In recent
studies, it was discovered that jusbetonin and its analogues had moderate proliferation
inhibitory rates from 21 % to 38 % on the human breast cancer cell line (MDA-231) at a
concentration of 1 µM.23 These analogues of jusbetonin were synthesized by the
introduction of sugar derivatives onto the indoloquinoline core by amidation of several
tetracyclic carboxylic acids, Figure 2.26.24

Figure 2.26: Current strategy by Liue et al. to synthesize jusbetonin-like products

Liue et al. did not demonstrate the ability to synthesize jusbetonin, Figure 2.10.
These analogues show linkage of the sugar to the quindoline through amide formation;
although, jusbetonin has a bond connection from the anomeric carbon of the sugar to the
heterocycle’s which should be an ester. The starting material, 2-aminobenzoic acid, could
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be replaced with 2-aminophenol to synthesize jusbetonin; however, Liue and co-authors
did not mention the attempt to synthesize this natural product with this synthetic route.
Using our research strategies, a photoprecursor can be designed to target this natural
product jusbetonin (Figure 2.27).

Figure 2.27: Retrosynthetic route to justbetonin

Here, the retrosynthetic route is similar to that of cryptolepine. The idea is to
synthesize a similar indole with a methoxy substituent. We could easily purchase
compound 2.98; however, we wanted to demonstrate that we can use inexpensive starting
materials to synthesize our substrates on a multigram scale.

Figure 2.28
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After isolating 2-amino-3-methoxybenzonitrile, we used the previous method to
synthesize the indole, Figure 2.29.

Figure 2.29

We synthesized photoprecursor 2.94 using indole 2.103, which was irradiated to
get product 2.93. The photoproduct could then be modified under basic conditions to afford
product 2.92, which can be reduced to the alcohol with BBr3.

Figure 2.30: Synthesis of justbetonin via aza-o-xylylene intermediate
and postphotochemical modifications
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2.5 Scope of Photo-precursors, Products, and Post-Photochemical Transformations

Table 3
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2.6 Conclusion
We have shown that we can expand the synthetically useful ESIPT generated azao-xylylene to target specific natural products. Through our studies, we had limitations on
the protecting groups; however as expected, the photochemical step functioned for each
photoprecursor. We can continue to target other conjugated polyheteroaromatic
compounds as well as polyheterocyclic sheets.
We took advantage of the modular assembly of the precursors through available
chemical feedstock, simple sp2-sp2 coupling, and high yielding reactions. The
photoprecursors were introduced into a photochemical step giving access to complex
polyheterocyclic architectures, which can undergo subsequent modifications. The postphotochemical transformation allows for a fully aromatic, flat polyheterocyclic structures.
With our optimized conditions, we can make the photoprecursors in one flask. Moreover,
the photochemical step and post-photochemical modifications are also a one pot synthesis.
Next, simple chemical reactions are introduced to target the natural product.
With our ambitious research, we have extended our research with methylation of
the final compounds to test for biological activity. With our interest in the biological
activity of methylated indoloquinoline, we continue to gather information of these
compounds to send to National Cancer Institute.
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2.7 Experimental
2.7.1 General Methods
Dibenzylation (General Procedure B)

Primary indole amines (2.6 mmol) in DMF (10 mL) were added dropwise to a
stirring solution of NaH (60w% dispersion in mineral oil 0.32 g, 8.0 mmol) in DMF (10
mL) at 0oC under nitrogen. After 10 minutes of stirring, benzyl bromide (0.94 mL,
5.4mmol) in DMF (20 mL) was added dropwise. The reaction was left overnight at room
temperature. Upon completion (as indicated by 1H NMR), the reaction was quenched with
water (20mL), and the reaction mixture was partitioned between ethyl acetate (100 mL)
and water (20 mL). The organic layer was separated, washed with water (2x10 mL), dried
over anhydrous Na2SO4, and the solvent was removed under reduced pressure to afford
secondary anilines. The majority of products were purified by flash chromatography on
silica gel.
Photochemical [4+2] Diels Alder reaction (General procedure F)
Photoprecursor (0.5 mmol) was dissolved in Methanol (50 mL), and the solution
was degassed by bubbling nitrogen for 1 h. The mixture was irradiated with UV LEDbased illuminator, seven 2.9 W @ 365 nm LED Engin chips (or two for 1f) with reaction
progress monitored by 1H NMR. Photoprecursors converted 100 % to photoproduct and
was modified in one step.
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Base promoted aromatization (General procedure G)
Photoprecursor (0.5 mmol) was irradiated according to General Procedure F. The
photoproduct in solution was transferred into a round bottom flask with K2CO3 (1.1 mmol).
This solution was refluxed and stirred at 75 °C until completion (monitored by 1H NMR).
Volatiles were evaporated under reduced pressure, and the residue was redissolved in DCM
(15 mL). Solution was washed 2 times with water (5 mL). Aqueous layer was extracted
with DCM (2x10 mL). The combined organic layer was washed with water (10 mL) and
brine (10 mL), dried over anhydrous Na2SO4, and the solvent was removed in vacuo.
Further purification by flash chromatography on silica gel yielded modified photoproducts
in 43-88% yields (after two steps).
Methylation (General procedure K)

Modified products (1.5 mmol) were dissolved in DCM (1 mL) and added to a 10
mL round bottom flask. Methyl triflate (1.7 mmol) was added to the reaction at room
temperature and the reaction flask was heated to reflux. Reaction was monitored by NMR
and completed after 1 hour. The reaction was cooled and the solvent was evaporated under
reduced pressure. The crude product was dissolved in ethyl acetate and sonicated for 5
minutes. The reaction mixture was filtered over celite. The solid is the salt product and was
dissolved in methanol giving pure compound.
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2.7.2 Synthesis of Photoprecursors

methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1H-indole2-carboxylate (2.1a):
benzyl 2-cyanophenylcarbamate (2.64): Compound was prepared according to a literature
protocol.2 A mixture of 2-aminobenzonitrile (1.00 g, 6.8 mmol) and benzyl chloroformate
(CbzCl) (30 g, 25 mL, 17 mmol) was heated in a round bottom flask equipped with a stir
bar and a reflux condenser at 100 o C for 3 h. The reaction mixture was maintained under
nitrogen atmosphere while allowing for the escape of excess pressure buildup. The reaction
mixture was allowed to cool down to room temperature. Et2O (30 mL) was added to the
reaction mixture and it was sonicated for 10 minutes and stirred for 20 minutes. The
mixture was filtered and washed with Et2O (20 mL). The ether filtrate was treated with
hexanes (100 mL) causing the precipitation of the corresponding N-benzyloxy carbamate
that was filtered and air dried overnight affording 1.33 g (68 %) of white solid.
methyl 2-((benzyloxycarbonyl)(2-cyanophenyl)amino)acetate (2.65): A solution of (2.2 g,
8.7 mmol, 1 equiv.) carbamate ester 2.64 in dry DMF (15 mL) was added to the suspension
of NaH (0.43 g of 60 w% dispersion in mineral oil, 10.7 mmol, 1.2 equiv.) in dry DMF (10
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mL) at room temperature. The reaction was maintained under a nitrogen atmosphere. The
solution was stirred at room temperature for 10 minutes. Then, methyl bromoacetate (1.49
g, 9.9 mmol, 1.1 equiv.) was added to this solution dropwise. The reaction was stirred at
room temperature for 12 h and was monitored by 1H NMR. For work up, the reaction was
quenched with water (10 mL) and ethyl acetate was added (30 mL). The ethyl acetate phase
was washed with water (2 x 20 mL), dried over Na2SO4 and evaporated under reduced
pressure to produce the crude product. Purified 2.65 was separated from impurities by flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1)
affording 2.74 g (95 %) of brown liquid.
1-benzyl 2-methyl 3-amino-1H-indole-1,2-dicarboxylate (2.66): A solution of methyl 2((benzyloxycarbonyl)(2-cyanophenyl)amino)acetate 2.65 (3.0 g, 9.5 mmol, 1 equiv.) in
dry DMF (15 mL) was added gradually to the suspension of NaH (0.46 g, of 60 w%
dispersion in mineral oil, 11.4 mmol, 1.2 equiv.) in dry DMF (15 mL) and maintained at 40 o C under nitrogen atmosphere. The reaction mixture was monitored by 1H NMR. Once
the completion was ensured, aqueous saturated NH4Cl (5 mL) was added to the reaction
mixture while it was maintained at -40 o C. The reaction mixture was diluted with ethyl
acetate (30 mL) and washed with water (2 x 20 mL). The ethyl acetate layer was dried over
Na2SO4 and evaporated under reduced pressure to produce the crude cyclized product.
Purified 2.66 was separated from impurities by flash chromatography on silica gel (gradient
elution: hexane → hexane–ethyl acetate 3:1) affording 2.9 g (94 %) of yellow liquid.
methyl 3-amino-1H-indole-2-carboxylate (2.67): (1.86 g, 10 % by weight) of Pd-C (10
w%) was added to a solution of 1-benzyl 2-methyl 3-amino-1H-indole-1,2-dicarboxylate
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2.66 (18.5 g, 57.4 mmol) in EtOH (50 mL). The solution was initially purged with
hydrogen gas then maintained under hydrogen atmosphere for 12 h at room temperature.
The contents of the reaction were filtered through Celite® and washed with EtOH (2 x 10
mL). The filterate and washings were combined and evaporated under reduced pressure to
produce the crude product. The crude product was separated by flash chromatography on
silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1) afforded 9.8 g (90 %) of
yellow solid.
methyl 1-benzyl-3-(benzylamino)-1H-indole-2-carboxylate (2.68): General procedure B
was followed on a (1.7 g, 8.9 mmol, 1 equiv.) scale of methyl 3-amino-1H-indole-2carboxylate 2.67 in DMF (20 mL). This solution was added to NaH (60w% dispersion in
mineral oil 0.89 g, 22.3 mmol, 2.5 equiv.) in DMF (10 mL) at 0oC under nitrogen. The
reaction was left stirring for 15 minutes, then Benzyl bromide (2.23 mL, 18.8 mmol, 2.1
equiv.) in DMF (30 mL) was added dropwise. The bis and dibenzylated products were
separated by flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl
acetate 3:1) affording 2.3 g (70 %) of yellow solid.
methyl

1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1H-indole-2-

carboxylate (2.1a): (0.70 g, 1.9 mmol, 1 equiv.) of the secondary aniline 2.68 was coupled
with oxalyl chloride (1.6 mL, 18.9 mmol, 10 equiv.), and the resulting acyl chloride was
coupled with 2-(1,3-dioxolan-2-yl)aniline (0.34 g, 2.1 mmol, 1.1 equiv.) by General
procedure C affording 1.07 g (96 %). Dioxolane protection was then removed according
to general procedure E with (0.54 mmol) p-TsOH·H2O, which after flash chromatography
on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1) afforded 0.90 g (92 %)
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of the title compound as yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 12.25 (s, 1H),
9.98 (d, J = 0.7 Hz, 1H), 8.47 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 7.6, 1.6 Hz, 1H), 7.66 (dt,
J = 8.1, 1.0 Hz, 1H), 7.50 (ddd, J = 8.7, 7.3, 1.7 Hz, 1H), 7.41 – 7.32 (m, 2H), 7.30 – 7.20
(m, 7H), 7.20 – 7.16 (m, 3H), 6.94 – 6.84 (m, 2H), 5.73 (s, 2H), 5.53 (d, J = 13.5 Hz, 1H),
4.63 (d, J = 13.5 Hz, 1H), 3.41 (s, 3H).13C NMR (126 MHz, CDCl3) δ 194.8, 163.8, 160.7,
159.7, 139.4, 137.8, 137.4, 135.9, 135.7, 135.7, 130.1, 128.5, 128.1, 128.0, 127.1, 126.3,
125.9, 123.8, 123.6, 123.3, 123.1, 122.5, 121.9, 120.1, 120.0, 111.1, 53.8, 51.6, 48.0.
HRMS (ESI) calcd for C33H28N3O5 + (MH+) 546.2029, found 546.2028

methyl

1-benzyl-3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2-oxoacetamido)-1H-

indole-2-carboxylate (2.2a): (0.34 g, 0.92 mmol, 1 equiv.) of the secondary aniline 2.68
was coupled with oxalyl chloride (0.78 mL, 9.2 mmol, 10 equiv.), and the resulting acyl
chloride was coupled with 2-amino-3-formylpyridine (0.11 g, 0.92 mmol, 1 equiv.)
General procedure D, which after flash chromatography on silica gel (gradient elution:
hexane → hexane–ethyl acetate 3:1) afforded 0.31 g (62 %) of the title compound as white
solid. 1H NMR (500 MHz, CDCl3) δ 12.02 (s, 1H), 9.94 (s, 1H), 8.59 (dd, J = 4.8, 1.9 Hz,
1H), 8.04 (dd, J = 7.6, 2.0 Hz, 1H), 7.55 (s, 1H), 7.33 – 7.17 (m, 11H), 7.05 – 6.92 (m, 2H),
5.81 (d, J = 16.5 Hz, 1H), 5.51 (d, J = 16.4 Hz, 2H), 4.63 (s, 1H), 3.43 (s, 3H).13C NMR
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(126 MHz, CDCl3) δ 192.5, 163.0, 160.8, 153.9, 150.8, 143.4, 137.9, 137.4, 135.7, 130.2,
128.5, 128.2, 128.1, 128.1, 128.0, 127.1, 126.1, 126.1, 123.2, 123.0, 121.5, 120.1, 119.3,
117.9, 111.0, 54.1, 51.6, 48.3. HRMS (ESI) calcd for C32H27N4O5 + (MH+) 547.1981,
found 547.1978

methyl

1-benzyl-3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2-oxoacetamido)-1H-

indole-2-carboxylate (2.3a): (0.30 g, 0.80 mmol, 1 equiv.) of the secondary aniline 2.68
was coupled with oxalyl chloride (0.68 mL, 8.0 mmol, 10 equiv.), and the resulting acyl
chloride was coupled with 2-amino-3-formylpyridine (0.10 g, 0.80 mmol, 1 equiv.)
General procedure D, which after flash chromatography on silica gel (gradient elution:
hexane → hexane–ethyl acetate 3:1) afforded 0.42 g (89 %) of the title compound as white
solid. 1H NMR (500 MHz, CDCl3) δ 12.09 (s, 1H), 10.13 (s, 1H), 8.79 (d, J = 8.8 Hz, 1H),
8.49 (dd, J = 4.5, 1.5 Hz, 1H), 7.64 (d, J = 7.9 Hz, 1H), 7.41 – 7.34 (m, 3H), 7.26 (ddd, J
= 10.0, 5.5, 2.5 Hz, 4H), 7.22 – 7.16 (m, 5H), 6.89 (dd, J = 6.7, 2.9 Hz, 2H), 5.71 (s, 2H),
5.52 (d, J = 13.5 Hz, 1H), 4.60 (d, J = 13.5 Hz, 1H), 3.40 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 196.9, 196.3, 163.2, 160.6, 160.1, 146.2, 145.0, 139.5, 137.9, 137.7, 137.4,
136.9, 135.5, 134.8, 130.1, 128.5, 128.4, 128.2, 128.1, 127.6, 127.2, 126.4, 125.9, 124.2,
123.4, 123.4, 122.9, 122.0, 119.9, 111.2, 53.9, 51.7, 48.0.
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Methyl-1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1Hpyrrolo[2,3-b]pyridine-2-carboxylate (2.4a):
benzyl 3-cyanopyridin-2-ylcarbamate (2.106): A mixture 2-aminonicotinonitrile (1.00 g,
6.8 mmol, 1 equiv.) and benzyl chloroformate (CbzCl) (1.9 mL,13.6 mmol, 2 equiv.) was
dissolved in DCM (20 mL). Triethylamine (1.00 mL, 7.2 mmol, 1.1 equiv.) was added drop
wise at 0 °C and the reaction mixture was maintained under nitrogen atmosphere while
allowing for the escape of excess pressure buildup. The reaction mixture was quenched
with water and worked up with DCM (2x20mL) and washed with water (2x20mL) the
organic phase was dried over Na2SO4 and evaporated under reduced pressure. After
purification by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 3:1) afforded 1.33 g (68 %) of bright yellow solid.
methyl 2-((benzyloxycarbonyl)(3-cyanopyridin-2-yl)amino)acetate (2.107): A solution of
(2.3 g, 9.1 mmol, 1 equiv.) carbamate ester 2.106 in dry DMF (15 mL) was added to the
suspension of NaH (0.44 g of 60 w% dispersion in mineral oil, 11.0 mmol, 1.2 equiv.) in
dry DMF (10 mL) at room temperature. The reaction was maintained under a nitrogen
atmosphere. The solution was stirred at room temperature for 10 minutes. Then, methyl
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bromoacetate (11.0 mmol) was added to this solution dropwise. The reaction was stirred at
room temperature for 12 h and was monitored by 1H NMR. For work up, the reaction was
quenched with water (10 mL) and ethyl acetate was added (30 mL). The ethyl acetate phase
was washed with water (2 x 20 mL), dried over Na2SO4 and evaporated under reduced
pressure to produce the crude product. Purified 2.107 was separated from impurities by
flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1)
affording 2.5 g (85 %) of bright yellow liquid.
1-benzyl 2-methyl 3-amino-1H-pyrrolo[2,3-b]pyridine-1,2-dicarboxylate (2.108): A
solution of methyl 2-((benzyloxycarbonyl)(3-cyanopyridin-2-yl)amino)acetate 2.107 (0.25
g, 7.7 mmol, 1 equiv.) in dry DMF (10 mL) was added gradually to the suspension of NaH
(0.37 g, of 60 w% dispersion in mineral oil, 9.0 mmol, 1.2 equiv.) in dry DMF (10 mL)
and maintained at -40 o C under nitrogen atmosphere. The reaction mixture was monitored
by 1H NMR. Once the completion was ensured, aqueous saturated NH4Cl (5 mL) was
added to the reaction mixture while it was maintained at -40 o C. The reaction mixture was
diluted with ethyl acetate (30 mL) and washed with water (2 x 20 mL). The ethyl acetate
layer was dried over Na2SO4 and evaporated under reduced pressure to produce the crude
cyclized product. Purified 2.108 was separated from impurities by flash chromatography
on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1) affording 2.2 g (88 %)
of yellow liquid.
methyl 3-amino-1H-pyrrolo[2,3-b]pyridine-2-carboxylate (2.109): (0.22 g, 10 % by
weight) of Pd-C (10 w%) was added to a solution of 1-benzyl 2-methyl 3-amino-1Hpyrrolo[2,3-b]pyridine-1,2-dicarboxylate 2.108 (2.2 g, 6.8 mmol) in EtOH (50 mL). The
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solution was initially purged with hydrogen gas then maintained under hydrogen
atmosphere for 12 h at room temperature. The contents of the reaction were filtered through
Celite® and washed with EtOH (2 x 10 mL). The filterate and washings were combined
and evaporated under reduced pressure to produce the crude product. The crude product
was separated by flash chromatography on silica gel (gradient elution: hexane → hexane–
ethyl acetate 3:1) afforded 1.2 g (92 %) of yellow solid.
Methyl-1-benzyl-3-(benzylamino)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

(2.110):

General procedure B was followed on a (0.21 g, 1.1 mmol, 1 equiv.) scale of methyl 3amino-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 2.109 in DMF (10 mL) and was added to
NaH (60w% dispersion in mineral oil 0.10 g, 2.5 mmol, 2.3 equiv.) in DMF (10 mL) at
0oC under nitrogen. The reaction was left stirring for 15 minutes, then benzyl bromide (0.27
mL, 2.3 mmol, 2.1 equiv.) in DMF (20 mL) was added dropwise. The bis and dibenzylated
products were separated by flash chromatography on silica gel (gradient elution: hexane
→ hexane–ethyl acetate 3:1) affording 0.34 g (82 %) of yellow solid.
Methyl-1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1Hpyrrolo[2,3-b]pyridine-2-carboxylate (2.4a): (0.32 g, 0.85 mmol, 1 equiv.) of the secondary
aniline 2.110 was coupled with oxalyl chloride (0.72 mL, 8.5 mmol, 10 equiv.), and the
resulting acyl chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.15 g, 0.93 mmol,
1.1 equiv.) by General procedure C affording 0.36 g (72 %). Dioxolane protection was then
removed according to general procedure E with 0.18 mmol of p-TsOH·H2O, which after
flash chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1)
afforded 0.21 g (85 %) of the title compound as yellow liquid. 1H NMR (500 MHz,
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Chloroform-d) δ 12.22 (s, 1H), 9.96 (d, J = 0.7 Hz, 1H), 8.53 (dd, J = 4.6, 1.6 Hz, 1H),
8.39 (d, J = 8.4 Hz, 1H), 7.79 (dd, J = 8.0, 1.6 Hz, 1H), 7.70 (dd, J = 7.7, 1.7 Hz, 1H), 7.51
(ddd, J = 8.7, 7.4, 1.7 Hz, 1H), 7.28 – 7.15 (m, 7H), 7.14 – 7.09 (m, 3H), 6.96 – 6.89 (m,
2H), 6.10 – 5.68 (m, 2H), 5.20 (d, J = 13.6 Hz, 1H), 4.84 (d, J = 13.6 Hz, 1H), 3.48 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ 194.8, 163.6, 160.4, 159.5, 147.9, 147.1, 139.2, 138.2,

136.0, 135.7, 135.6, 130.0, 128.9, 128.3, 128.3, 128.1, 126.9, 126.2, 123.8, 123.3, 122.5,
122.2, 119.9, 118.1, 116.0, 54.1, 51.9, 46.2. HRMS (ESI) calcd for C32H27N4O5 + (MH+)
547.1981, found 547.1980.

methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-7-methoxy1H-indole-2-carboxylate (2.5a): (0.34 g, 0.85 mmol, 1 equiv.) of the secondary aniline
2.98 was coupled with oxalyl chloride (0.72 g, 8.5 mmol, 10 equiv.), and the resulting acyl
chloride was coupled with 2-(1,3-dioxolan-2-yl)aniline (0.15 g, 0.93 mmol, 1.1 equiv.) by
General procedure C affording 0.21 g (40 %). Dioxolane protection was then removed
according to general procedure E with 0.08 mmol of p-TsOH·H2O, which after flash
chromatography on silica gel (gradient elution: hexane → hexane–ethyl acetate 3:1)
afforded 0.14 g (61 %) of the title compound as yellow liquid.1H NMR (500 MHz, CDCl3)
δ 12.20 (s, 1H), 9.97 (d, J = 0.7 Hz, 1H), 8.48 (d, J = 8.5 Hz, 1H), 7.72 – 7.66 (m, 1H),
7.51 (ddd, J = 8.7, 7.3, 1.7 Hz, 1H), 7.27 – 7.19 (m, 8H), 7.16 (t, J = 7.9 Hz, 1H), 7.14 –
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7.09 (m, 2H), 6.85 – 6.81 (m, 2H), 6.78 (dd, J = 7.8, 1.0 Hz, 1H), 6.06 (s, 2H), 5.54 (d, J =
13.5 Hz, 1H), 4.51 (d, J = 13.4 Hz, 1H), 3.82 (s, 3H), 3.33 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 194.8, 163.8, 160.5, 159.7, 148.2, 140.0, 139.5, 135.9, 135.7, 135.7, 130.1, 128.2,
128.1, 128.1, 127.9, 127.8, 126.5, 125.7, 125.3, 124.2, 123.9, 123.6, 122.4, 122.3, 120.0,
112.2, 106.5, 55.6, 53.6, 51.6, 50.3.
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2.7.3 Irradiation of Photoprecursors
Photochemical [4+2] Diels Alder reaction (General procedure F)
Photoprecursor (0.5 mmol) was dissolved in Methanol (50 mL), and the solution was
degassed by bubbling nitrogen for 1 h. The mixture was irradiated with UV LED-based
illuminator, seven 2.9 W @ 365 nm LED Engin chips (or two for 1f) with reaction progress
monitored by 1H NMR. Photoprecursors converted 100 % to photoproduct and was
modified in one step.

Photoprecursor

Photoproduct

2.1b

2.2b

2.3b

111

LED Power Reaction
(W)

time (h)

20

8

20

5

20

14

2.4b

2.5b

20

6

20

7

2.7.4 Post-photochemical Modifications

10-benzyl-10H-indolo[3,2-b]quinolone (2.1c): General procedure G was followed on a
(0.15 g, 0.28 mmol) scale of photoproduct 2.1b in 50 mL of methanol. The reaction was
left at 75°C for 4 days, after work up and purification by flash chromatography on silica
gel (gradient elution: hexane → hexane–ethyl acetate 5:1); which after two steps afforded
75 mg (85 %) of the title compound as a yellow solid. 1H NMR (500 MHz, Chloroform-d)
δ 8.65 – 8.58 (m, 1H), 8.40 – 8.32 (m, 1H), 7.95 (s, 2H), 7.93 (d, J = 1.3 Hz, 1H), 7.69
(ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.64 (ddd, J = 8.4, 7.2, 1.3 Hz, 1H), 7.56 (ddd, J = 8.1, 6.8,
1.2 Hz, 1H), 7.44 (d, J = 8.2 Hz, 1H), 7.39 (t, J = 7.5 Hz, 1H), 7.35 – 7.29 (m, 2H), 7.25 –
7.18 (m, 2H), 5.60 (s, 2H).

13

C NMR (126 MHz, CDCl3) δ 146.2, 144.7, 144.3, 136.4,
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133.8, 129.9, 129.3, 129.0, 127.8, 127.2, 126.9, 126.4, 126.4, 125.4, 122.3, 121.9120.1,
111.4, 108.9, 46.8. HRMS (ESI) calcd for C22H17N2 + (MH+) 309.1392, found 309.1401.

10-benzyl-10H-indolo[3,2-b][1,5]naphthyridine (2.3c): General procedure G was
followed on a (0.10 g, 0.20 mmol) scale of photoproduct 2.3b in 50 mL of methanol. The
reaction was left at 75°C for 3 days, after work up and purification by flash chromatography
on silica gel (gradient elution: hexane → hexane–ethyl acetate 4:1); which after two steps
afforded 37 mg (78 %) of the title compound as a yellow solid. 1H NMR (500 MHz,
CDCl3) δ 8.99 (t, J = 2.8 Hz, 1H), 8.66 (d, J = 8.5 Hz, 1H), 8.60 (d, J = 7.8 Hz, 1H), 8.22
(s, 1H), 7.70 (t, J = 7.7 Hz, 1H), 7.63 (dd, J = 8.5, 4.1 Hz, 1H), 7.51 (d, J = 8.3 Hz, 1H),
7.43 (t, J = 7.5 Hz, 1H), 7.29 (s, 13H), 5.62 (s, 2H).

17‐benzyl‐9,15,17‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐
octaene (2.4c): General procedure G was followed on a (0.27 g, 0.49 mmol) scale of
photoproduct 2.4b in 50 mL of methanol. The reaction was left at 75 oC for 4 days, after
work up and purification by flash chromatography on silica gel (gradient elution: hexane
→ hexane–ethyl acetate 5:1); which after two steps afforded 64 mg (43 %) of the title
compound as a bright yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 8.84 (dd, J = 7.6,
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1.6 Hz, 1H), 8.69 (dd, J = 4.9, 1.6 Hz, 1H), 8.33 (d, J = 8.6 Hz, 1H), 7.95 (s, 1H), 7.93 (d,
J = 8.4 Hz, 1H), 7.70 (ddd, J = 8.4, 6.7, 1.4 Hz, 1H), 7.57 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H),
7.37 – 7.28 (m, 6H), 5.79 (s, 2H).

13

C NMR (126 MHz, CDCl3) δ 155.1, 149.7, 144.6,

143.7, 136.6, 132.8, 130.3, 129.2, 128.8, 127.7, 127.4, 127.1, 127.0, 126.9, 125.9, 116.2,
115.0, 112.8, 45.0. HRMS (ESI) calcd for C21H16N3 + (MH+) 310.1344, found 310.1344

2.7.5 Post-modifications
Base promoted debenzylation (General procedure H)

10h-indolo[3,2-b]quinolone (2.5):
10-benzyl-10H-indolo[3,2-b]quinoline 2.1c (25 mg, 0.08 mmol) was stirred in DMSO (5
mL) with excess of potassium tert-butoxide (26.9 mg, 0.24 mmol, 3 equiv.) at 50°C. Color
changed occurred from orange to bright red. The reaction had completed in 1 hour and was
quenched with Aq. NH4Cl (5 mL) at room temperature. The reaction was worked up with
ethyl acetate and water (2 x 25mL). The organic extracts were evaporated under reduced
pressure and purified by flash chromatography on silica gel (gradient elution: hexane →
hexane–ethyl acetate 5:1); which afforded 15 mg (86 %) of the title compound as a white
solid. 1H NMR (500 MHz, Chloroform-d) δ 8.57 (d, J = 7.8 Hz, 1H), 8.37 (d, J = 8.5 Hz,
1H), 8.34 (s, 2H), 8.05 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.69 (ddd, J = 8.3, 6.6, 1.4 Hz,
1H), 7.62 (t, J = 7.6 Hz, 1H), 7.57 (t, J = 7.5 Hz, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.36 (t, J =
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7.5 Hz, 1H).

13

C NMR (126 MHz, CDCl3) δ 146.5, 144.4, 143.6, 132.5, 129.9, 129.1,

127.2, 127.0, 126.6, 125.3, 122.2, 122.1, 120.4, 113.2, 111.0. HRMS (ESI) calcd for
C15H11N2 + (MH+) 219.0922, found 219.0925.

Methylation (General procedure J)

5-Methyl-5H-quindoline (Cryptolepine) (2.50): BaO (10 mg, 0.07 mmol, 1 equiv) and
KOH (3.9 mg, 0.07 mmol, 1 equiv.) was added to Acetone (5 mL). The Acetone was then
added to 10h-indolo[3, 2-b] quinolone 2.5 (15 mg, 0.07 mmol, 1 equiv) in a 25 mL round
bottom flask. The reaction was left to reflux at 60C for 15 minutes. Next, iodomethane
(0.35 mmol) was added to the reaction and was left at reflux for 1 hour. The reaction was
evaporated and packed inside a manual column. 30 mL (EtOAc-n-Heaxanes 10:1) was
added to column and collected. Next, 30 mL (EtOAc-n-Heaxanes 1:1) was added. Each
test tube was checked by TLC. Product was eluted in fractions with EtOAc-n-Heaxanes
10:1 affording 11 mg (68 %) of the title compound as a light-yellow solid. 1H NMR (500
MHz, Chloroform-d) δ 8.59 (d, J = 7.7 Hz, 1H), 8.37 (d, J = 8.5 Hz, 1H), 8.03 – 8.00 (m,
1H), 8.00 (s, 1H), 7.70 (ddt, J = 8.6, 6.7, 1.5 Hz, 2H), 7.59 (ddd, J = 8.1, 6.7, 1.3 Hz, 1H),
7.48 (d, J = 8.2 Hz, 1H), 7.42 – 7.33 (m, 1H), 3.94 (s, 3H). 13C NMR (126 MHz, CDCl3) δ
145.0, 144.1, 134.2, 129.7, 129.3, 127.2, 126.9, 126.2, 125.3, 122.1, 121.7, 119.7, 110.7,
108.4, 77.3, 77.0, 76.7, 29.7, 29.2.
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5-methylbenzofuro[3,2-b]quinolin-5-ium (2.78):
General procedure K was followed on a (21.9 mg, 0.10 mmol) scale of modified product
1.1c which after two steps afforded 18 mg (77 %) of the title compound as a yellow solid.
1

H NMR (500 MHz, Methanol-d4) δ 9.42 (s, 1H), 8.81 (d, J = 8.2 Hz, 1H), 8.75 (d, J = 9.1

Hz, 1H), 8.57 (d, J = 8.2 Hz, 1H), 8.33 (t, J = 7.9 Hz, 1H), 8.19 – 8.10 (m, 1H), 8.07 (q, J
= 7.9 Hz, 2H), 7.84 (t, J = 7.7 Hz, 1H), 5.11 (s, 3H). 13C NMR (126 MHz, MeOD) δ 160.9,
148.1, 143.1, 137.5, 136.1, 134.2, 130.5, 128.7, 127.7, 126.0, 125.8, 125.5, 117.6, 116.3,
113.4, 39.7.

5-methylbenzo[4,5]thieno[3,2-b]quinolin-5-ium trifluoromethanesulfonate (2.79):
General procedure K was followed on a (30.1 g, 0.14 mmol) scale of modified product
1.10c which after two steps afforded 14 mg (40 %) of the title compound as a yellow solid.
1H NMR (500 MHz, MeOD) δ 9.68 – 9.62 (m, 1H), 8.83 (d, J = 8.6 Hz, 1H), 8.45 – 8.32
(m, 2H), 8.21 (dd, J = 18.7, 9.0 Hz, 1H), 8.01 – 7.89 (m, 1H), 7.84 – 7.77 (m, 1H), 3.40 –
3.34 (m, 3H).13C NMR (126 MHz, MeOD) δ 146.7, 144.5, 140.1, 137.1, 134.5, 133.5,
133.5, 128.6, 128.6, 126.8, 126.4, 126.4, 124.9, 124.0, 120.0, 22.8.
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1-methylpyrido[3',2':4,5]thieno[3,2-b]quinolin-1-ium

trifluoromethanesulfonate

(2.80): General procedure K was followed on a (30 mg, 0.10 mmol) scale of modified
product 1.12c which after two steps afforded 16 mg (63 %) of the title compound as a
yellow solid. 1H NMR (500 MHz, Methanol-d4) δ 9.53 (d, J = 8.0 Hz, 1H), 9.26 (s, 1H),
9.23 (d, J = 6.4 Hz, 1H), 8.36 (d, J = 8.6 Hz, 1H), 8.25 (t, J = 7.1 Hz, 1H), 8.21 (d, J = 8.4
Hz, 1H), 8.01 (t, J = 7.7 Hz, 1H), 7.85 (t, J = 7.6 Hz, 1H), 4.66 (s, 3H). 13C NMR (126
MHz, MeOD) δ 158.6, 148.1, 147.2, 146.6, 137.8, 134.3, 132.1, 131.0, 128.9, 128.2, 127.9,
127.8, 123.0, 46.0. HRMS (ESI) calcd for C15H11N2S + (MH+) 251.0643, found 251.0644
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Chapter Three
Rearrangement to Pyridopyrimidone Cores via Solvolysis of Primary
Photoproducts
3.1 Background of Pyrimidines
Drug discovery requires libraries of more complex and diverse molecules, which
have privileged natural product-like substructures, but they are challenging to synthesize.
Current synthetic efforts are broadly focused on developing experimentally straightforward
synthetic routes to natural and non-natural products that are biological active. In order to
investigate a variety of non-natural products, recent research uses short synthetic routes to
target complex motifs that are interesting to study.
Nitrogen fused heterocylic systems containing indole, pyridine, and pyrole have
shown a trend in biological activity. Specifically, pyrido[1,2-a]pyrimidines show
biological activity as antifungal, antiulcerative, anti-inflammatory, and antiviral drugs.25
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Figure 3.1: Biologically active agents consisting of pyrido[1,2-a]pyrimidine

Purine bases of RNA and DNA as well as biologically active natural products are
known to have a pyrimidine unit; therefore, it was reported that pyrido[1,2-a]pyrimidines
are useful building blocks in the synthesis of useful drugs.
Doad et al. was able to synthesize these pyrido[1,2-a]pyrimidines with mode of
cyclization; however, only with ester side chains. Moreover, molecules are limited with
diversity because complexity can only be built on one side of these pyrido[1,2-a]pyrimidine
compounds (Figure 3.1).26 They were able to utilize heterocyclic compounds involving
nitrogen and sulfur as nucleophiles in Michael additions followed by cyclization with
dimethyl allene-1.3-dicarboxylate.
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Figure 3.2: Synthesis of bicyclic and tricyclic heterocyclic pyrimidines

Queiroz et al. was able to synthesize benzothieno[3,2-d]pyrido[1,2-a]pyramid-6ones by Buchwalk-Hartwig C – N coupling, followed by an intramolecular cyclization
(Figure 3.3).27 This method was widespread; however, bromo-benzenes bearing an
electron-donating group did not transpire. Also, this reaction was limited to
benzo[b]thiophenes.

Figure 3.3: Synthesis of benzothieno[3,2-d]pyrido[1,2-a]pyramid-6-ones
by C – N coupling and intramolecular cyclization.

Though there are limitations to the scope of this reaction, the reaction is efficient
with the coupling occurring first and subsequent cyclization. The palladium catalyst was
introduced to the ligand, Xantphos, which then offered palladium zero. The palladium zero
120

catalyst underwent oxidative addition with 2-bromopyridine to yield intermediate 3.16.
The contribution of cesium carbonate to the reaction offered an exchange with the halide,
allowing for transmetalation between the catalyst and benzothiophene. After reductive
elimination, product 3.19 underwent spontaneous intramolecular cyclization to achieve the
desired benzothieno[3,2-d]pyrido[1,2-a]pyramid-6-one 3.13.

Figure 3.4: Mechanism of the Buchwald Hartwig coupling reaction and intramolecular cyclization yielding
benzothieno[3,2-d]pyrido[1,2-a]pyramid-6-ones

121

3.2 Access to Pyrimidines
3.2.1 Photochemical Pathway to [4+2] Cycloadditions
Previous work has shown it to be difficult to synthesize complex pyrido[1,2a]pyrimidines due to its lack of construct flexibility; photochemistry gives alternative
pathways to complex structures. Here, we display [4+2] intramolecular cycloadditions
of azaxylylenes. These photoprecursors are accessible through standard amide bondforming reactions. The intermediates are produced by the excited state intramolecular
proton transfer (ESIPT) from photoprecursors that could be trapped intramolecularly by
tethered unsaturated pendants. As a result, the photoactive core and unsaturated pendants
can be designed to target specific natural and non-natural products. After strategically
designing these photoprecursors, the primary photoproducts are amenable for
straightforward post-photochemical modifications.

Figure 3.5: Synthesis of photoprecursor

We can easily access these photoprecursors through simple stepwise reactions with
oxalyl chloride, as seen in Figure 3.5. The photoprecursors contain indole, thiophene, and
furan as the unsaturated pendent, which is then coupled to oxalyl chloride, followed by
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addition of the amino aldehyde. This can do an excited state intramolecular proton transfer
(ESIPT) to form a triplet diradical, which was described previously.

Figure 3.6: Photochemical reaction via ESIPT

3.2.2 Rearrangement During Post-Photochemical Modification
Previously in our research, the post-photochemical modification offered aromatic
polyheterocycles. However, in the course of our preliminary studies we discovered a
rearrangement that occurred when the photoactive core is a pyridine aldehyde. During the
basic aromatization, there are two outcomes: aromatization or solvolysis.

Figure 3.7: Two alternative routes of based-catalyzed modifications
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Scheme 3.7 outlines the outcomes of the post-photochemical modification and the
mechanistic hypothesis of the solvolysis rearrangement. We were able to isolate the formyl
product 3.32, allowing us to rationalize this mechanism. Our proposition is that the retroClaisen condensation occurs faster than the ester hydrolysis, producing the shown
pyridopyrimidone core. The sulfur atom provides stabilization to the anion, which allows
for the cyclization of product 3.31 which followed by deformylation, gives the final product
3.27. We also tried to isolate each intermediate of the proposed mechanism. We
successfully isolated compounds 3.33 and 3.34 from two different reactions.

Figure 3.8: Isolated intermediates

Rearrangements continued with a variety of unsaturated pendants and the
rearrangement was successful with indole and benzofuran; however, it did not work with
different photoactive cores.

Figure 3.9: Scope of pyramidones

Though we were able to isolate these compounds, which most have never been
synthesized before, we wanted to increase complexity of these compounds with known
124

reactions from previous lab members. Our idea was to isolate the intermediate with the
formyl group attached, so we can use this very reactive substituent to couple with an
aniline. This could be achieved with minimal steps (Figure 3.10). Previously, Dr. Sai Doda
Reddy was able to irradiate imines to undertake electrocyclization, which we wanted to
incorporate into this research.

Figure 3.10

Unfortunately, these are still in progress due to the complexity and issues with their
solubility. We are continuing to study these rearranged structures and utilizing their
intermediates, so we can access complex architectures.
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3.3 Experimental
3.3.1 General Procedures

Base-Catalyzed Post-Photochemical Rearrangement (General Procedure L)
(0.21 mmol) was charged with 3 equivalents of potassium carbonate at room
temperature, then the reaction was heated to 75 oC. The reaction was evaporated and
worked up with ethyl acetate and water and purified by LC.

Isolation of Intermediates (General Procedure M)
The photoproduct (0.24 g, 0.50 mmol, 1 equiv.) above was dissolved into methanol
and potassium carbonate (0.08 g, 0.68 mmol, 1.4 equiv.) was added to the reaction flask.
After 5 hours and stirring at room temperature, a singlet showed on NMR spectra at 10
ppm. This is a significant for an aldehyde peak. Next, the reaction was purified by LC.
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Formation of Imine (General Procedure N)
The formyl product (0.20 mmol) was dissolved in dry DCM and MS were added.
The aniline (0.30 mmol) was added to the reaction mixture and left overnight. The reaction
was monitored with NMR. When the aldehyde peak was consumed, the reaction was
complete.
3.3.2 Synthesis of Rearranged Products

11-(dimethoxymethyl)-7λ4-benzo[4,5]thieno[3,2-d]pyrido[1,2-a]pyrimidin-6(12H)one (3.35): General procedure M was followed on a (37.9 mg, 0.080 mmol) scale of
photoproduct which after two steps afforded 12 mg (45 %) of the title compound as a white
solid.1H NMR (500 MHz, CDCl3) δ 9.15 (dd, J = 7.2, 1.7 Hz, 1H), 8.51 (d, J = 7.9 Hz,
1H), 8.00 (dd, J = 6.9, 1.7 Hz, 1H), 7.97 (d, J = 8.1 Hz, 1H), 7.72 – 7.64 (m, 1H), 7.58 (t,
J = 7.5 Hz, 1H), 7.18 (t, J = 7.0 Hz, 1H), 6.36 (s, 1H), 3.64 (s, 6H).

6-(Dimethoxymethyl)-10

λ4-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-

11(5H)-one (3.33): General procedure M was followed on a (0.15 g, 0.32 mmol) scale of
photoproduct which after two steps afforded 60 mg (57 %) of the title compound as a
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yellow liquid. 1H NMR (500 MHz, CDCl3) δ 9.18 (dd, J = 7.2, 1.7 Hz, 1H), 8.86 (dd, J =
4.6, 1.8 Hz, 1H), 8.74 (dd, J = 8.0, 1.8 Hz, 1H), 8.14 – 7.92 (m, 1H), 7.54 (dd, J = 8.0, 4.6
Hz, 1H), 7.23 (t, J = 7.1 Hz, 1H), 6.34 (s, 1H), 3.61 (s, 6H). 13C NMR (126 MHz, CDCl3)
δ 163.9, 154.5, 151.7, 151.2, 147.8, 133.7, 132.3, 128.6, 126.8, 120.1, 114.4, 114.0, 99.7,
55.1.

11H-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-11-one

(3.3a):

General

procedure L was followed on a (0.15g, 0.32 mmol) scale of photoproduct which afforded
23 mg (28 %) of the title compound as a yellow solid. 1H NMR (500 MHz, CDCl3) δ 9.18
(dt, J = 7.3, 1.2 Hz, 1H), 8.86 (dd, J = 4.6, 1.8 Hz, 1H), 8.73 (dd, J = 8.0, 1.7 Hz, 1H), 7.83
(dt, J = 9.0, 1.3 Hz, 1H), 7.78 (ddd, J = 9.1, 6.4, 1.5 Hz, 1H), 7.55 (dd, J = 8.0, 4.6 Hz,
1H), 7.21 (ddd, J = 7.7, 6.5, 1.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 163.8, 154.5,
151.9, 151.7, 149.6, 134.9, 132.2, 128.5, 126.7, 126.3, 120.3, 114.8, 114.3

6H-benzofuro[3,2-d]pyrido[1,2-a]pyrimidin-6-one (3.1a): General procedure L was
followed on (0.29 g, 0.61 mmol) scale and was dissolved in 3 mL of methanol and
completed overnight (12h) which afforded 65 mg (48 %) as a white solid. 1H NMR (500
MHz, CDCl3) δ 9.26 (dt, J = 7.3, 1.2 Hz, 1H), 8.25 (dt, J = 7.9, 1.0 Hz, 1H), 7.94 – 7.81
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(m, 1H), 7.79 – 7.65 (m, 3H), 7.51 (td, J = 7.4, 7.0, 1.1 Hz, 1H), 7.18 (ddd, J = 7.6, 6.6, 1.4
Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 158.2, 149.2, 149.1, 145.7, 133.9, 132.9, 130.8,
127.4, 126.4, 124.0, 122.6, 122.2, 114.2, 113.0.

5-benzylpyrido[1',2':1,2]pyrimido[5,4-b]indol-6(5H)-one (3.4a):General procedure L
was followed on (0.273 g, 0.50 mmol) scale and was dissolved in 3 mL of methanol and
completed after 4 days, which afforded 34 mg (21 %) as a yellow liquid.1H NMR (500
MHz, CDCl3) δ 9.16 (dt, J = 7.4, 1.2 Hz, 1H), 8.76 (dd, J = 4.7, 1.7 Hz, 1H), 8.66 (dd, J =
7.8, 1.7 Hz, 1H), 7.79 (d, J = 9.1 Hz, 1H), 7.59 (ddd, J = 9.1, 6.4, 1.6 Hz, 1H), 7.52 – 7.40
(m, 2H), 7.34 (dd, J = 7.9, 4.7 Hz, 1H), 7.30 – 7.19 (m, 4H), 7.06 (ddd, J = 7.6, 6.4, 1.4
Hz, 1H), 6.18 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 151.4, 151.1, 150.3, 146.6, 139.4,
138.5, 132.0, 130.6, 128.9, 128.5, 127.9, 127.4, 126.4, 126.2, 116.7, 116.0, 113.8, 113.4,
46.4
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Appendices
Appendix A: List of Abbreviations
Ac

acetyl

anhydr.

anhydrous

aq.

aqueous

Ar

aryl

Bn

benzyl

calcd

calculated

cat.

catalyst (or catalytic amount)

CbzCl

benzylchloroformate

CHCl3

chloroform

CH3I

iodomethane

(COCl)2

oxayl chloride

d

doublet

dd

doublet of doublets

ddd

doublet of doublet of doublets

dddd

doublet of doublet of doublet of doublets

dt

doublet of triplets

DCM

dichloromethane

DFT

density functional theory

DIPEA

N,N-diisopropylethylamine

DMF

dimethylformamide
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DMSO

dimethyl sulfoxide

DPPE

1,2-bis(diphenylphosphino)ethane

ESIPT

excited state intramolecular proton transfer

Et

ethyl

EtOAc

ethyl acetate

EtOH

ethanol

EWG

electron withdrawing group

eq

equivalent

g

gram(s)

h

hour(s)

ISC

intersystem crossing

HPLC

high-performance liquid chromatography

HRMS

high-resolution mass spectrum

hv

light (irradiation)

K2CO3

potassium carbonate

KOtBu

potassium tert-butoxide

LED

light emitting diode

LC

liquid chromatography

mA

milli amperes

Me

methyl

mg

milligram(s)

min

minute(s)
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MS

mass spectroscopy

NaOH

sodium hydroxide

Na2SO4

sodium sulfate

NMR

nuclear magnetic resonance

Ph

phenyl

Py

pyridine

q

quartet

r.t.

room temperature

s

singlet

S1

first singlet excited state

sat.

saturated

t

triplet

T1

first triplet excited state

T2

second triplet excited state

TBPB

tert-butyl peroxybenzoate

TEA

triethylamine

THF

tetrahydrofuran

TMS

trimethylsilane

TMSCl

trimethylsilyl chloride

UV

ultraviolet

V

volt(s)

W

Watts(s)
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Appendix B: NMR Spectra of Photoprecursors

1

H Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino) – 2 -oxoacetamido)benzofuran-2carboxylate (1.1a)

13

C Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino) – 2 -oxoacetamido)benzofuran-2carboxylate (1.1a)
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1

H Spectra of ethyl 3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2-oxoacetamido)benzofuran-2carboxylate (1.2a)

13

C Spectra of ethyl 3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2-oxoacetamido)benzofuran-2carboxylate (1.2a)
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1

H Spectra of ethyl 3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2-oxoacetamido)benzofuran-2carboxylate (1.3a)

13

C Spectra of ethyl 3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2-oxoacetamido)benzofuran-2carboxylate (1.3a)
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1

H Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)furo[2,3-b]pyridine-2carboxylate (1.8a)

13

C Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)furo[2,3-b]pyridine-2carboxylate (1.8a)

139

1

H Spectra of methyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)benzo[b]thiophene-2carboxylate (1.10a)

13

C Spectra of methyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)benzo[b]thiophene-2carboxylate (1.10a)
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1

H Spectra of methyl 3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2-oxoacetamido)benzo[b]thiophene2-carboxylate (1.11 a)
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1

H Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)thieno[2,3-b]pyridine-2carboxylate (1.12a)

13

C Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)thieno[2,3-b]pyridine-2carboxylate (1.12a)
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1

H Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)thieno[3,2-b]pyridine-2carboxylate (1.14a)

13

C Spectra of ethyl 3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)thieno[3,2-b]pyridine-2carboxylate (1.14a)
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1

H Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1H-indole-2carboxylate (2.1a)

13

C Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1H-indole-2carboxylate (2.1a)
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1

H Spectra of methyl 1-benzyl-3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2-oxoacetamido)-1Hindole-2-carboxylate (2.2a)

13

C Spectra of methyl 1-benzyl-3-(N-benzyl-2-(3-formylpyridin-2-ylamino)-2-oxoacetamido)-1Hindole-2-carboxylate (2.2a)
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1

H Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylpyridin-3-ylamino)-2-oxoacetamido)-1Hindole-2-carboxylate (2.3a)
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1

H Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1Hpyrrolo[2,3-b]pyridine-2-carboxylate (2.4a)

13

C Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-1Hpyrrolo[2,3-b]pyridine-2-carboxylate (2.4a)
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1

H Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-7-methoxy1H-indole-2-carboxylate (2.5a)

13

C Spectra of methyl 1-benzyl-3-(N-benzyl-2-(2-formylphenylamino)-2-oxoacetamido)-7-methoxy1H-indole-2-carboxylate (2.5a)
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Appendix C: NMR Spectra of Post-Photochemical Transformation

1

H Spectra of benzofuro[3,2-b]quinolone (1.1c)

13

C Spectra of benzofuro[3,2-b]quinolone (1.1c)
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1

H Spectra of benzofuro[3,2-b][1,8]naphthyridine (1.2c)

13

C Spectra of benzofuro[3,2-b][1,8]naphthyridine (1.2c)
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1

H Spectra of 17‐oxa‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.3c)

13

C Spectra of 17‐oxa‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.3c)
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1

H Spectra of benzo[b]benzofuro[2,3-g][1,8]naphthyridine (1.4c)

13

C Spectra of benzo[b]benzofuro[2,3-g][1,8]naphthyridine (1.4c)
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1

H Spectra of benzofuro[2,3-g]naphtho[1,2-b][1,8]naphthyridine (1.5c)

13

C Spectra of benzofuro[2,3-g]naphtho[1,2-b][1,8]naphthyridine (1.5c)
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HSQC Spectra of benzofuro[2,3-g]naphtho[1,2-b][1,8]naphthyridine (1.5c)
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1

H Spectra of benzofuro[2,3-e]thieno[3,2-b]pyridine (1.6c)

13

C Spectra of benzofuro[2,3-e]thieno[3,2-b]pyridine (1.6c)
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1

H Spectra of (1.7c)
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1

H Spectra of 17‐oxa‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.8c)

13

C Spectra of 17‐oxa‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.8c)

157

HSQC Spectra of 17‐oxa‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.8c)

158

1

H Spectra of 17‐oxa‐7,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.9c)

13

C Spectra of 17‐oxa‐7,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.9c)

159

HSQC Spectra of 17‐oxa‐7,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐
octaene (1.9c)
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1

H Spectra of 17‐thia‐9‐azatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene (1.10c)

13

C Spectra of 17‐thia‐9‐azatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene (1.10c)
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1

H Spectra of 17‐thia‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.11c)

13

C Spectra of 17‐thia‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.11c)
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HSQC Spectra of 17‐thia‐4,9‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.11c)
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1

H Spectra of 17‐thia‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.12c)

13

C Spectra of 17‐thia‐9,15‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.12c)

164

1

H Spectra of 17‐thia‐4,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.13c)

13

C Spectra of 17‐thia‐4,9,15‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐octaene
(1.13c)

165

1

H Spectra of 17‐thia‐9,14‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.14c)

13

C Spectra of 17‐thia‐9,14‐diazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1,3,5,7,9,11(16),12,14‐octaene
(1.14c)
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1

H Spectra of (1.17c)

167

1

H Spectra of 10-benzyl-10H-indolo[3,2-b]quinolone (2.1c)

13

C Spectra of 10-benzyl-10H-indolo[3,2-b]quinolone (2.1c)
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1

H Spectra of 17‐benzyl‐9,15,17‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐
octaene (2.4c)

13

C Spectra of 17‐benzyl‐9,15,17‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐1(10),2,4,6,8,11,13,15‐
octaene (2.4c)

169

HSQC Spectra of 17‐benzyl‐9,15,17‐triazatetracyclo[8.7.0.03,8.011,16]heptadeca‐
1(10),2,4,6,8,11,13,15‐octaene (2.4c)
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Appendix D: NMR Spectra of Post-Modification Products

1

H Spectra of 10h-indolo[3,2-b]quinolone (2.5)

13

C Spectra of 10h-indolo[3,2-b]quinolone (2.5)
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1

H Spectra of 5-Methyl-5H-quindoline (Cryptolepine) (2.50)

13

C Spectra of 5-Methyl-5H-quindoline (Cryptolepine) (2.50)

172

HSQC Spectra of 5-Methyl-5H-quindoline (Cryptolepine) (2.50)
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1

H Spectra of 5-methylbenzofuro[3,2-b]quinolin-5-ium (2.78)

13

C Spectra of 5-methylbenzofuro[3,2-b]quinolin-5-ium (2.78)

174

HSQC Spectra of 5-methylbenzofuro[3,2-b]quinolin-5-ium (2.78)
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1

H Spectra of 1-methylpyrido[3',2':4,5]thieno[3,2-b]quinolin-1-ium trifluoromethanesulfonate (2.80)

13

C Spectra of 1-methylpyrido[3',2':4,5]thieno[3,2-b]quinolin-1-ium trifluoromethanesulfonate (2.80)

176

HSQC Spectra of 1-methylpyrido[3',2':4,5]thieno[3,2-b]quinolin-1-ium trifluoromethanesulfonate
(2.80)

HMBC Spectra of 1-methylpyrido[3',2':4,5]thieno[3,2-b]quinolin-1-ium trifluoromethanesulfonate
(2.80
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Appendix E: NMR Spectra of Rearrangement

1

H Spectra of 11-(dimethoxymethyl)-7λ4-benzo[4,5]thieno[3,2-d]pyrido[1,2-a]pyrimidin-6(12H)-one
(3.35)

178

1

H Spectra of 6-(Dimethoxymethyl)-10λ4-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin11(5H)-one (3.33)

13

C Spectra of 6-(Dimethoxymethyl)-10λ4-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin11(5H)-one (3.33)
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1

H Spectra of 11H-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-11-one (3.3a)

13

C Spectra of 11H-pyrido[1,2-a]pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-11-one (3.3a)
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1

H Spectra of 6H-benzofuro[3,2-d]pyrido[1,2-a]pyrimidin-6-one (3.1a)

13

C Spectra of 6H-benzofuro[3,2-d]pyrido[1,2-a]pyrimidin-6-one (3.1a)
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1

H Spectra of 5-benzylpyrido[1',2':1,2]pyrimido[5,4-b]indol-6(5H)-one (3.4a)

13

C Spectra of 5-benzylpyrido[1',2':1,2]pyrimido[5,4-b]indol-6(5H)-one (3.4a)

182

HSQC Spectra of 5-benzylpyrido[1',2':1,2]pyrimido[5,4-b]indol-6(5H)-one (3.4a)
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